CA2194071C - Non-linear control systems and methods for heating and ablating body tissue - Google Patents

Non-linear control systems and methods for heating and ablating body tissue Download PDF

Info

Publication number
CA2194071C
CA2194071C CA002194071A CA2194071A CA2194071C CA 2194071 C CA2194071 C CA 2194071C CA 002194071 A CA002194071 A CA 002194071A CA 2194071 A CA2194071 A CA 2194071A CA 2194071 C CA2194071 C CA 2194071C
Authority
CA
Canada
Prior art keywords
power
electrode
value
delta
operating condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002194071A
Other languages
French (fr)
Other versions
CA2194071A1 (en
Inventor
Roger A. Stern
Dorin Panescu
David K. Swanson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Ltd Barbados
Original Assignee
Boston Scientific Ltd Barbados
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Ltd Barbados filed Critical Boston Scientific Ltd Barbados
Publication of CA2194071A1 publication Critical patent/CA2194071A1/en
Application granted granted Critical
Publication of CA2194071C publication Critical patent/CA2194071C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00084Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00084Temperature
    • A61B2017/00101Temperature using an array of thermosensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00292Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00292Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
    • A61B2017/003Steerable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00477Coupling
    • A61B2017/00482Coupling with a code
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00059Material properties
    • A61B2018/00071Electrical conductivity
    • A61B2018/00083Electrical conductivity low, i.e. electrically insulating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00059Material properties
    • A61B2018/00089Thermal conductivity
    • A61B2018/00095Thermal conductivity high, i.e. heat conducting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00059Material properties
    • A61B2018/00089Thermal conductivity
    • A61B2018/00101Thermal conductivity low, i.e. thermally insulating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00172Connectors and adapters therefor
    • A61B2018/00178Electrical connectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • A61B2018/00357Endocardium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577Ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00642Sensing and controlling the application of energy with feedback, i.e. closed loop control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00666Sensing and controlling the application of energy using a threshold value
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00684Sensing and controlling the application of energy using lookup tables
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/0069Sensing and controlling the application of energy using fuzzy logic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/00702Power or energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00779Power or energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • A61B2018/00797Temperature measured by multiple temperature sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • A61B2018/00803Temperature with temperature prediction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • A61B2018/00815Temperature measured by a thermistor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00827Current
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00869Phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00875Resistance or impedance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00892Voltage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/0091Handpieces of the surgical instrument or device
    • A61B2018/00916Handpieces of the surgical instrument or device with means for switching or controlling the main function of the instrument or device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00988Means for storing information, e.g. calibration constants, or for preventing excessive use, e.g. usage, service life counter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • A61B2018/124Generators therefor switching the output to different electrodes, e.g. sequentially
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • A61B2018/1246Generators therefor characterised by the output polarity
    • A61B2018/1253Generators therefor characterised by the output polarity monopolar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • A61B2018/1246Generators therefor characterised by the output polarity
    • A61B2018/126Generators therefor characterised by the output polarity bipolar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/1425Needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/1435Spiral
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/08Accessories or related features not otherwise provided for
    • A61B2090/0803Counting the number of times an instrument is used
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/08Sensors provided with means for identification, e.g. barcodes or memory chips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/27General characteristics of the apparatus preventing use
    • A61M2205/273General characteristics of the apparatus preventing use preventing reuse, e.g. of disposables
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/60General characteristics of the apparatus with identification means
    • A61M2205/6018General characteristics of the apparatus with identification means providing set-up signals for the apparatus configuration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/60General characteristics of the apparatus with identification means
    • A61M2205/6027Electric-conductive bridges closing detection circuits, with or without identifying elements, e.g. resistances, zener-diodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/70General characteristics of the apparatus with testing or calibration facilities
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/50Temperature

Abstract

Systems and methods employ an energy emitting electrode (16) to heat tissue. The systems and methods control the application of energy to the electrode (16) using adjustments that take into account, in a non-linear fashion, changes in monitored operating conditions.

Description

W O 96!00528 PCT/US95I07960 NON-LINEAR CODTTROL BYBTEBdB AND HETHODS
FOR HEATING AND ABLATING BODY TISSOE
Eisld of the Invention In a general sense, the 'invention is directed to systems and methods for creating lesions in the interior regions of the human body. In a more particular sense, the invention is directed to systems and methods for ablating heart tissue for treating cardiac conditions.

Backcround of the Invention Physicians frequently make use of catheters today in medical procedures to gain access into interior regions of the body. In some procedures, the catheter carries an energy emitting element on its distal tip to ablate body tissues.

In such procedures, the physician must establish stable and uniform contact between the energy emitting element and the tissue to be ablated. Upon establishing contact, the physician must then carefully apply ablating energy to the element for transmission to the tissue.

The need for precise control over the emission of ablating energy is especially critical during catheter-based procedures for ablating heart tissue. These procedures, called -electrophysiology ' therapy, are becoming increasingly more widespread for treating cardiac rhythm disturbances, called arrhythmias. Cardiac ablation procedures typically use radio frequency (RF) energy to form a lesion in heart tissue.
The principal objective of the invention is to provide systems and methods for monitoring and reliably controlling the application of energy to ablate body tissue, thereby providing therapeutic results in a consistent and predictable fashion.
Summary of the Invention The invention provides systems and methods that provide reliable control over tissue heating and ablation procedures using temperature sensing. According to the invention, the systems and methods control the application of energy to an energy emitting electrode using power adjustments that take into account, in a non-linear fashion, changes in monitored operating conditions.
According to a broad aspect, the invention provides an apparatus for supplying energy to an electrode for ablating tissue comprising a first processing stage to monitor a selected operating condition of the electrode, derive from the monitored operating condition a predicted operating value for a future time (VD), compare the derived predicted operating value for a future time VD to a preselected set operating value (VS) for the operating condition, and establish an error signal (D), where:
d = VS-VD, and a second processing stage to issue a command signal Scow to adjust power to the electrode above a zero value, thereby maintaining power without interruption, where:
S'con~vD = f f 4 J
and where f is a nonlinear function.

- 2a -According to another broad aspect, the invention provides an apparatus for supplying energy to an electrode for ablating tissue comprising a first processing stage to monitor a selected operating condition of the electrode, derive from the monitored operating condition a predicted operating value for a future time (VD), compare the derived predicted operating value for a future time VD to a preselected set operating value (VS) for the operating condition, and establish an error signal (D), where:
d = VS-VD, and a second processing stage to issue a command signal SCOT to adjust power to the electrode above a zero value, thereby maintaining power without interruption, where:
SCOMMAND - f ~4 2 i 42 i 4 3 i ... , where f is a N-variable nonlinear function that describes the first processing stage and D1, ~z, 03, ..., ~N are the values of the error signal D at N different moments of time.
According to a further broad aspect, the invention provides an apparatus for supplying energy to an electrode for ablating tissue comprising a power source adapted to be electrically coupled to the electrode to supply energy to the electrode for ablating tissue, and a controller coupled to the power source to supply power to the power source, the controller comprising a first processing stage to monitor a selected operating condition, derive from the monitored operating condition an operating value (VD), compare the derived operating value VD to a preselected set value (VS) for the operating condition, and establish an error signal (D), where:
3 0 D = VS-VD, and - 2b -a second processing stage to incrementally adjust the power supplied to the electrode according to the following expression:
D P = f ~ SgCALE X d J
where: DP is the incremental power adjustment; f is a mathematical function; and SSCALE is a nonlinear scaling factor that equals a first value (X) when D > Z and equals a second value (Y), different than X, when D < Z, where Z is a desired D.
According to a still further broad aspect, the invention provides an apparatus for supplying energy to an electrode for ablating tissue comprising a power source adapted to be electrically coupled to the electrode to supply energy to the electrode for ablating tissue, and a controller coupled to the power source to supply power to the power source, the controller comprising a first processing stage to monitor operating conditions and derive a power control signal SDERZVED based upon a first monitored operating condition, and a second processing stage to compare a second monitored operating condition with preselected criteria for the second operating condition, generate an error signal (E) when the second operating condition fails to meet the preselected criteria, and issue a command signal Soon to set power supplied to the power source, wherein, absent the error signal E, Soon sets the power according to SDERIVEDi and wherein, when the error signal E is generated, Soon sets the power at a prescribed low power condition (PLOW) , regardless of Soon, PLOW being a value above zero.
According to yet another broad aspect, the invention provides an apparatus for supplying energy to an electrode for ablating tissue comprising a power source - 2c -adapted to be electrically coupled to the electrode to supply energy to the electrode for ablating tissue, and a controller coupled to the power source to supply power to the power source, the controller comprising a first processing stage to monitor operating conditions and derive a power control signal SDERZVED based upon a first monitored operating condition, and a second processing stage to compare a second monitored operating condition with preselected criteria for the second operating condition, generate an error signal (E) when the second operating condition fails to meet the preselected criteria, derive impedance and issue a command signal Soon to set power supplied to the power source, wherein, absent the error signal E, SCOT sets the power according to SDERIVED, and wherein, when the error signal E is generated, Soon sets the power at a prescribed low power condition (PLOw).
regardless of Soon. PLOW being a value above zero to permit derivation of impedance by the second processing stage.
One aspect of the invention provides an apparatus and associated method for supplying energy to an electrode for ablating tissue. The apparatus and method monitor a selected operating condition of the electrode and derive from it an operating value (VD). The apparatus and method include a processing element that compares the derived operating value VD to a preselected set value (VS) for the operating condition to establish an error signal (D), where:
4 - Vs-VD .
According to the invention, VS can either be a fixed, prescribed value or expressed in terms of a value that varies with time as a set temperature curve.
The apparatus and method further issue a command signal SCOT, where:

- 2d -Scor~r~vD = f ~W , 4z, 43, ..., aN~
where, in the general sense, f is a N-S W O 96100528 219 4 071 pCT~595107960 variable nonlinear function that describes the processing element and ~~, ai, L~ , ... ,~ are the values of the error signal D at IJ different moments of time. This means that the processing element can , 5 adjust the output signal Scup using a nonlinear function of the present and past values of the error signal D.
In a preferred embodiment, SNp can be expressed as:
'Scorarnnv f (.S scar~X ~) -where:
f is a function associated with the processing element (i.e., the algorithm used to analyze data), and Sac~~e is a nonlinear scaling factor that equals a first value (X) when D > a value Z and equals a second value (Y), different than X, when D
< Z, and Z is a desired D.
In a preferred embodiment, Z and, therefore the desired D is zero.
20~ In a preferred embodiment, the command signal Sc~~p adjust the level of power applied to the electrode. In this preferred embodiment, Y > X.
Due to the asymmetric, non-linear scaling factor Sscme~ the apparatus and method serve to decrease power to the electrode at a faster rate than increasing power to the electrode.
Another aspect of the invention provides an apparatus and associated method for supplying energy to an electrode for ablating tissue. The apparatus and method monitor operating conditions of the electrode. The apparatus and method derive a power control signal SpEeiveo based upon a monitored first operation condition. The apparatus and method also WO 96!00528 219 4 0 71 PCTIUS95107960 compare a monitored second operating condition with preselected criteria for the second operating condition and generate an error signal (E) when the , second operating condition fails to meet the preselected criteria. , According to this aspect of the invention, the apparatus and method issue a command signal ScoH~uwo to set power supplied to the electrode.
Absent the error signal E, Sc~~wp sets the power according to SoEa~~o. When the error signal E is generated, S~pNp sets the power at a prescribed low power condition (P~~) , regardless o~MAU~S .
According to a preferred aspect of the invention, P~ou is a selected value above zero but at a level that does not sustain tissue ablation over time.
In a preferred embodiment, P~ou is about 1 watt.
In a preferred embodiment, the second monitored operating condition includes a measurement of the power delivered by the generator. In this embodiment, the preselected criteria includes an established maximum power value.
In a preferred embodiment, the second monitored operating condition also includes a measurement of temperature at the electrode. In this embodiment, the preselected criteria includes an established maximum temperature value. In this embodiment, the preselected criteria can also include an established set temperature value adjusted by an established incremental value.
The apparatus and methods that embody the features of the invention are well suited for use in the field of cardiac ablation. They also are applicable for use in other tissue heating and ' ablation applications, as well. For example, the WO 96100528 Z 1 9 4 0 7 1 PC'TIUS95l07960 various aspects of the invention have application in procedures for ablating tissue in the prostrate, brain, gall bladder, uterus, and other regions of the body, using systems that are not necessarily catheter-based.
In a preferred embodiment, the apparatus and method also measure impedance. Because P~~ is above zero, impedance measurements can continue, even after tissue ablation has been halted.
Other features and advantages of the inventions are set forth in the following Description and Drawings, as well as in the appended claims.
Brief Description of the Drawings Fig. 1 is a perspective view of a system for ablating tissue that comprises an energy emitting electrode and associated energy generator;
Figs. 2, 3 and 4 are, respectively, an elevated side view, an end view, and a side section view (taken along line 4-4 in Fig. 3) of the electrode associated with the system shown in Fig.
1, the electrode having a temperature sensing element;
Fig: 5 is a schematic view of the generator for supplying energy to the electrode in the system shown in Fig. 1, the generator using a specialized modified PID control technique to maintain a desired set temperature by altering power in response to sensed temperature;
Figs. 6A and 6B are graphs showing curves of set temperature conditions for the generator to maintain over time;
Fig. 7 is a schematic view of an alternative system for use in association with the generator shown in Fig. 5 to alter applied power in WO 96/00528 ~ ~ 9 4 0 7 1 p~~S95/07960 response to sensed temperature, using adaptive control techniques;
Fig. 8 is a schematic view of a system for , use in association with the generator shown in Fig.
5 for scaling down power in response to prescribed , power or temperature conditions;
Fig. 9 is a schematic view of systems for use in association with the generator shown in Fig.
5 for establishing the maximum power condition for use by the scale back power system shown in Fig. 8;
Fig. 10 is a more detailed schematic view of one of the systems shown in Fig, 9 for automatically establishing the maximum power condition based upon the physical characteristics of the ablation electrode;
Figs. 11A and B are schematic views of the implementation of a neural network predictor to maintain a desired set temperature by altering power in response to a prediction of maximum tissue temperature; and Fig. 12 is a schematic view of the implementation of fuzzy logic to maintain a desired set temperature condition.
The invention may be embodied in several forms without departing from its spirit or essential characteristics. The scope of the invention is defined in the appended claims, rather than in the specific description preceding them. All embodi ments that fall within the meaning and range of equivalency of the claims are therefore intended to be embraced by the claims.
Bescription of the Preferred Embodiments ' Fig. 1 shows a system 10 for ablating human tissue that embodies the features of the invention.
In the illustrated and preferred .. _... i W O 96100528 PCTlUS95/07960 embodiment, the system 10 includes a generator 12 that delivers radio- frequency energy to ablate . tissue. Of course, other types of energy can be generated for tissue ablating purposes.
The system 10 also includes a steerable catheter 14 carrying a radio frequency emitting ablation electrode 16. In the illustrated embodiment, the ablation electrode 16 is made of platinum.
10~ In the illustrated embodiment, the system operates in a unipolar mode. In this arran-gement, the system 10 includes a skin patch electrode that -serves as an indifferent second electrode 18. In use, the indifferent electrode 18 attaches to the patient's back or other exterior skin area.
Alternatively, the system 10 can be operated in a bipolar mode. In this mode, the catheter 14 carries both electrodes.
The system 10 can be used in many different environments. This specification describes the sys-tem 10 when used to provide cardiac ablation therapy.
When used for this purpose, a physician steers the catheter 14 through a main vein or artery (typically the femoral vein or artery) into the interior region of the heart that is to be treated.
The physician then further manipulates the catheter 14 to place the electrode 16 into contact with the tissue within the heart that is targeted for ablation. The user directs radio frequency energy from the generator 12 into the electrode 16 to ablate and form a lesion on the contacted tissue.
I. THE ABLATION CATHETER _,_ In the embodiment shown in Fig. 1, the _ g _ catheter 14 includes a handle 20, a guide tube 22, and a distal tip 24, which carries the electrode 16.
The handle 20 encloses a steering mechanism 26 for the catheter tip 24. A cable 28 extending from the rear of the handle 20 has plugs (not shown). The plugs connect the catheter 14 to the generator 12 for conveying radio frequency energy to the ablation electrode 16.
Left and right steering wires (not shown) extend through the guide tube 22 to interconnect the steering mechanism 26 to the left and right sides of the tip 24.
Rotating the steering mechanism 26 to the left pulls on the left steering wire, causing the tip 24 to bend to the left.
Also, rotating the steering mechanism 26 to the right pulls on the right steering wire, causing the tip 24 to bend to the right. In this way, the physician steers the ablation electrode 16 into contact with the tissue to be ablated.
Further details of this and other types of steering mechanisms for the ablating element 10 are shown in Lunquist and Thompson U.S. Patent 5,254,088.
A. Temperature Sensing As Figs. 2 to 4 show, the ablation electrode 16 carries at least one temperature sensing element 30. As will be described in greater detail later, the power that the generator 12 applies to the electrode 16 is set, at least in part, by the temperature conditions sensed by the element 30.
In the embodiment illustrated in Figs. 3 to 4, the ablation electrode 16 includes an interior well 32 at its tip end. The temperature sensing W O 96f 00528 - - ~ PCTlUS95I07960 _ g _ element 30 occupies this well 32.
In Figs. 3 to 4, the temperature sensing element 30 includes a small bead thermistor 34 with two associated lead wires 36 and 38. The temperature sensing tip of the thermistor 34 is ex-posed at the tip end of the ablation electrode 16 for tissue contact. The thermistor 34 of the type shown is commercially available from the Fenwal Co.
(Massachusetts) under the trade designation 111-202CAK-BD1. The lead wires 36 and 38 comprise X36 AWG signal wire Cu+ clad steel (heavy insulation).
Potting compound 40 encapsulates the thermistor 34 and lead wires 36 and 38 within the electrode well 32. Insulating sheaths 42 also shield the encapsulated lead wires 36 and 38.
Together, the compound 40 and sheaths 42 electrically insulate the thermistor 34 from the surrounding ablation electrode 16.
The potting compound 40 and insulation sheathes 42 can be made with various materials. In the illustrated embodiment, loctite adhesive serves as the potting compound 40, although another cyanoacrylate adhesive, an RTV adhesive, polyurethane, epoxy, or the like could be used. The sheathes 42 are made from polyimide material, alth-ough other conventional electrical insulating materials also can be used.
In the illustrated and preferred embodiment, a thermal insulating tube 44 envelopes the encapsulated thermistor 34 and lead wires 36 and 38. The thermal insulation tube 44 can itself be adhesively bonded to the interior wall of the well 32.
The thermal insulating material of the tube 44 can vary. In the illustrated embodiment, it is a polyimide material having a wall thickness of about .003 inch. Other thermal insulating materials like Mylar~
or Kapton~ could be used.
The lead wires 36 and 38 for the thermistor 34 extend through the guide tube 22 and into the catheter handle 20. There, the lead wires 36 and 38 electrically couple to the cable 28 extending from the handle 20. The cable 28 connects to the generator 12 and transmits the temperature signals from the thermistor 34 to the generator 12.
In the illustrated and preferred embodiment (as Fig. 10 shows), the handle 20 carries a calibration element RCAL for the thermistor 34. The element RCaL accounts for deviations in nominal resistance among different thermistors. During manufacture of the catheter 10, the resistance of thermistor 34 is measured at a known temperature; for example, 75 degrees C. The calibration element REAL has a resistance value equal to the measured value. Further details of this will be discussed later.
II. THE RF GENERATOR
As Fig. 5 shows, the generator 12 includes a radio frequency power source 48 connected through a main isolation transformer 50 to outlet and return lines 52 and 54. Outlet line 52 leads to the ablation electrode 16. Return line 54 leads from the indifferent electrode 18.
In the illustrated embodiment, when used for cardiac ablation, the power source 48 is typically conditioned to deliver up to 50 watts of power at a radio frequency of 500 kHz.

- 10a -The generator 12 further includes a first processing stage 56. The first processing stage 56 receives as inputs an instantaneous power signal Vd0 96100528 ~ ~ PCT/US95I07960 P~t~, a set temperature value TSEr, and a temperature control signal T~NTROm Analyzing these inputs using prescribed criteria, the first processing stage 56 derives a demand power signal PpEmNO.
The generator 12 also includes a second processing stage 58. The second processing stage 58 receives as input the demand power signal PoE~ofrom the first processing stage 56. The second processing stage 58 also receives as inputs the instantaneous power signal P~t~ and a maximum power value~XP
Analyzing these inputs according to prescribed criteria, the second processing stage 58 adjusts the amplitude of the radio frequency voltage of the source, thereby adjusting the magnitude of the generated power, which P~t~ represents.
The generator 12 preferably includes an interactive user interface 13, which is only generally shown in schematic form in Fig. 1. It should be appreciated that the interface 13 can, in conventional ways, make full use of conventional input devices (for example, a key board or mouse);
output display devices (for example, a graphics display monitor or CRT); and audio and visual alarms.
~. The First Processing Stmae The generated power signal P~t~ input for the first processing stage 56 is generated by a multiplier 60. The multiplier 60 receives an instantaneous current signal I~t~ from an isolated current sensing transformer 62 and an instantaneous voltage signal V~t~ from an isolated voltage sensing transformer 64.
The isolated current sensing transformer 62 is electrically coupled to the return line 54. The transformer 62 measures the instantaneous radio frequency current I~t~ emitted by the ablation electrode 16 through body tissue to the indifferent electrode 18.
The isolated voltage sensing transformer 64 is electrically coupled between the outlet and return lines 52 and 54. The voltage sensing transformer 64 measures the instantaneous radio frequency voltage V~t~ across body tissue between the ablation electrode 16 and the indifferent electrode The multiplier 6o multiples I~t~ by V~t~ to derive the instantaneous radio frequency power P~t~, which passes through the low pass filter 61 to eliminate ripple. The filtered P~L~ serves as the power input signal for the first processing stage 56.
In the illustrated and preferred embodiment, the generator 12 includes, as part of its overall interface 13, a display 110 (see Fig. 1 also) to show P~t~.
The set temperature value Ts~r for the first processing stage 56 can be inputted by the physician through an interface 66, which is part of the overall interface 13 of the generator 12 (see Fig.
1 also) . The set temperature value T~Er represents the temperature the physician wants to maintain at the ablation site. The value Tser can be established in other ways. For example, the value T~Er can vary over time to define a set temperature curve.
Further details of this will be described later.
The set temperature value Tser selected depends upon the desired therapeutic characteristics of the lesion. Typical therapeutic lesion charac-teristics are the surface area of the tissue that is ablated and depth of the ablation. Typically, the ' W'096l00528 PCT/US95/07960 set temperature TAT is in the range of 50 to 90 degrees C.
The temperature control signal TooNreo~ input is based upon the actual instantaneous temperature conditions sensed TM~t~ by the sensing element 30.
In the particular illustrated embodiment, the first processing stage 56 receives as T~NTROL the output resistance value of the thermistor 84 (in ohms). It divides this resistance value by the calibration value R~~~ to normalize the resistance value of the thermistor 34. This normalized resistance value is the input to a read only memory (ROM) table in the generator 12, which contains stored thermistor temperature data. The ROM output is the actual measured temperature TH~t~ (in degrees C) .
The TH~t~ output is preferably shown in a display 68, which is part of the overall interface 13 for the generator 12 (see Fig. 1 also).
The actual instantaneous temperature TM~t>
can be used directly by the first processing stage 56. However, in the illustrated and preferred embodiment, the first processing stage 56 includes a predicted temperature processor 70 (PTP). The PTP
70 derives from TH~t~ a predicted temperature value (designated TPaEOCC~) (i) The Predicted Temperature Processor The PTP 70 continuously samples TM~~~ over prescribed sample periods ~Ts~P~E. Applying prescribed criteria to these samples, the PTP 70 predicts at the end of each sample period a temperature condition TPREOCL that would exist at the end of a future time period (greater than ~T~~E),assuming that power supplied to the ablating W0 96/00528 ' PCT/US95107960 electrode 16 is not changed. This future time period is called the prediction period OTPR~tcr~
The length of the prediction period ~TPREDICT -can vary. Its maximum length depends largely upon the thermal time constant of the tissue, to take , into account the expected physiological response of the tissue to temperature conditions generated during ablation. The prediction period ~TP~ICr should not exceed the time period at which the tissue can be expected to experience cellular transformation when exposed to ablating heat.
In the case of heart tissue, the thermal time constant is such that the maximum length of the prediction period ~TP~~cr should typically not exceed about two seconds. After about two seconds, cardiac tissue can be expected to begin experiencing cellular-transformation when exposed to the range of temperatures generated during ablation.
ATs~P~E is selected to be smaller than ~TPREOICW The PTP 70 measures the instantaneous temperature TH~t~ at the end of the present sample period and compares it to the measured temperature at the end of one or more preceding sample periods TM~t_~~, where n is the number of preceding sample periods selected for comparison. Based upon the change in the measured temperature over time during the selected sample periods, and taking into account the relationship between the magnitude of oT~P~E and ~TPREDICT~ the PTP 70 predicts TpRencc) as follows:
__ i+K _ K
TPAEDIt) TM(t)~ i ~ TMIt-i)~ ~~
where:

W096f00528 ~~~~ ~ PCTIUS95/07960 K- ~TPAEDICT _ _.
~T~LE
and i = 1 to n.
In a representative implementation of the PTP 70 for cardiac ablation, ~TPR~ICr is selected to be 0.48 second, and oTs~P~E is selected to be 0.02 second (a sampling rate of 50Hz). Therefore, in this implementation, K = 24.
Furthermore, in this implementation, n is selected to be 1. That is, the PTP-70 takes into account TN~L~ for the instant sample period (t) and TM~t_~~ for the preceding sample period (t-1) .
In this implementation, the PTP 70 derives Traeocc) as follows:
TrxEDtey25TMtef-24TMe-m In the illustrated and preferred embodiment, the PTP 70 includes a low pass filter 72 with a selected time constant (z). The PTP 70 averages TppED(L) t~'ough the filter 72 before supplying it -to a demand power processor DPP 76, which will be described later.
The time constant (z) of the filter 72 selected can vary, according to the degree of accuracy desired. Generally speaking, a mid-range time constant (z) of about 0.2 second to about 0.7 second will provide the required accuracy. In the above described representative implementation, a time constant (z) of 0.25-second is used.
The degree of accuracy of the PTP 70 can also be altered by varying K. More particularly, by lowering the value of K, one can expect the PTP 70 to achieve a greater degree of accuracy in predicting the future temperature TP~octo The value of K can be varied by selecting values for ~Ts~~E or ~TPREDICT~ or both. Preferably, the value of K is varied by selecting ~TPREOtcm The degree of accuracy PTP 70 can also be improved, if desired, by selecting greater values for n; that is, by taking into account more past values of TH~t~ in calculating TPReocc>
In the illustrated and preferred embodiment, the PTP 70 includes a user interface 74, which is part of the overall interface 13 of the generator 12 (see Fig. 1 also). Using the interface 74, the physician can select and modify the sampling history (n) ; the prediction period ~TPREO,cr% and the time constant (r) in real time, on line.
As will be described in greater detail later, the ability to vary the accuracy of the PTP
70 in calculating TPREOCt~ with on line changes provides flexibility in adapting the first processing stage 56 to differing ablating conditions.
(ii) The Demand Power Processor (DPP) The first processing stage 56 further includes a demand power processor (DPP) 76. The DPP
76 periodically compares TppED(t) to the set temperature value TrET. Based upon this comparison, and taking into account the magnitude of the instantaneous power P~t~ supplied to the ablating electrode 16, the DPP 76 derives the demand power output PpE~NO. The DPP76 also takes into account other system operating goals and criteria, like response time, steady state temperature error, and maximum temperature overshoot. ' The demand power output PpE~o of the first processing stage 56 represents the magnitude of the ' radio frequency power that should be supplied to the ~194U1i ~~ V170 96100528 PCTlUS95/07960 _ 17 _ ablating electrode 16 to establish or maintain the desired local temperature condition Tser at the ablating electrode 16.
The manner in which the DPP 76 derives Pp~a~
can vary. For example, it can employ proportional control principles, proportional integral derivative (PID) control principles, adaptive control, neural network, and fuzzy logic control principles.
(a) Modifisd PID Control Using Fized T~
In the illustrated and preferred embodiment, the DPP 76 employs a modified velocity PID control technique specially adapted for cardiac ablation. Using this technique, the DPP 76 controls the magnitude of PpEHauo based upon a fixed value of Tser established by the physician.
In the preferred and illustrated implementation, the DPP 76 compares a derived operating value Vp to a preselected set value (yV ) for the operating condition. The DPP 76 establishes an error signal (°) based upon the comparison, where:
The DPP 76 issues the power demand signal for the next time period PoEruNUtt+» based upon a non-linear function of the present and past values of the error signal °, i.e.,:
Pr~rmtmce.pf~°y°2~°s~ ~..,°N) In the general sense, f is a N-variable nonlinear function that the DPP 76 follows in performing its processing functir~n. °~, °Z, °3, ...
,°N are the values of the error signal ° at N
different moments of time. The DPP 76 thereby adjusts the power by an increment based upon a nonlinear function of the present and past values of the error signal D.
More particularly, in the illustrated and preferred implementation, at the end of each sample period (t), the DPP 76 derives the demand power output required for the next sample period (t+1), as follows:
PD(e.lyPte~+SfaE~t~-aECe-W +bE~t_zn where the nonlinear function f(~) is expressed as:
f(d)=SfaE~e) pe-yEle-z1) the error signal D is expressed as E~L~
where Vp is T~~ and VS is TSEr, so that E~i~ = TSET
TPR~~t~. In this implementation, a threshold value of TseT is selected, which remains essentially constant ns TPRED(t) ~-S determined by the PTP 70, and a, p, and 6 are conventional velocity PID expressions based upon a proportional constant ICp (relating to the magnitude of the difference); an integral constant K~ (relating to the change in the difference over time); and a derivative constant Kd (relating to rate at which the difference is changing over time) ; and ~Tg~nP~E, as follows:
o(=K + Ki~Tsnt~r.~+ Kd P
2 ~TSa~LE
~- K ~ TS~LE _ K _ 2 Kd P
2 OTsnr~~

W O 96100528 ~ ~ ~ ~ ~ PCT/US95/07960 Ka ~TSl~zs and and S is a selected scaling factor, whose value depends upon whether TPREDtt) is greater than or less than TsEr , as follows:
S = X when E(t) > 0 (i.e., TsEr >
TPRED(t)) S = Y when E(t) < 0 (i.e., TsEr <
TPRED(t)) ~ and The value of S is asymmetric;
1o that is, X is different than Y and, most preferably, Y > X.
The above relationships assume that the desired error E(t) to be maintained is zero. Other desired error values could be used. Using the asymmetric scaling factor S provides the desired nonlinear response f(~) over time to maintain the desired error E(t). In maintaining the desired error at zero, the f(~) of the DPP 76 decreases power faster (when TpRED(t) > sTEr ) than increasing power (when TPREDtt) < Tser) In the illustrated and preferred embodiment, the DPP 76 uses fired values for the coefficients RP, K~ , ands K , regardless of the particular ablating conditions.
The calculation for PD~D can be adapted on line by the physician to changing ablating conditions encountered, by adjusting the front end calculation of TP~D(t) by the PTP 70. Because of the flexibility to make on line adjustments that the PTP
70 provides, multiple value tables of KP, K1, and Kd are not necessary in the system to accommodate changes in ablating conditions.

?_194071 W0 96/00528 PCTlUS95107960 i Applicants have determined that the following values of for ICP, K~, and Kd can be used in the DPP 76:
KP = 0.025375 Ri = 97.0695 Rd = 7.82 x 10-5 In a representative implementation of the DPP 76, ~TSANPLE = 0 ~ 02 , and therefore a = 0.99998 (3 = 0.93750 b = 3.91 x 103. -In this representative implementation of the DPP 76, S = 2.0 when E~tr > 0 (i.e., S~ >
TPRED(t)) ~ and S = 8.0 when Ert~ < 0 (i.e., ~r <
TPRED ) This representative implementation adjusts PDElIAND(t) to reach TSEr t 3° C within 5.0 seconds, if not limited by available power. It also aims to keep a peak steady state temperature error (defined as TsEr - pRED(t) ) of less than 3° C. The implementation also adjusts PD~DCC~ over time to avoid overshooting TSEr by more than 3° C.
(b) Modified PID Control Using Varipble Tar In an alternative embodiment, the DPP 76 uses modified velocity PID control described above to control the magnitude of PDERnRD based upon varying values of TsEr over time. In this embodiment, TSEr is expressed-as a function with respect to time (see Figs. 6A and 6B), which can be linear or nonlinear or both. In this embodiment, TrEr comprises a temperature versus time curve (see Figs. 6A and 6B) ,.~ VH096i00528 21 ~ PCT/US95107960 for heating tissue. The curve has a first temperature value set at a first time period and at least one additional temperature value, different than the first temperature value, set at a second time period after the first time period.
As Fig. 6A shows, TseT can be expressed in terms of a linear function at the outset of the ablation procedure (for example, during the first 5 seconds). From t=0 to t=5 seconds, the value of Tser l0 progressively increases as a straight line with a selected slope. At t=6 seconds, Tser begins to be expressed in term of a nonlinear function, so that the slope flattens out as Tser approaches a preselected final control value for ablation.
In an alternative implementation (shown in Fig. 6B), the Tssr defines a complex curve to accommodate thermal mapping before thermal ablation.
As Fig. 6B shows, from t=0 to t=2 seconds, the value of T~~ progressively increases as a straight line with a selected slope. At t=3 seconds, Tser begins to be expressed in term of a nonlinear function, and the slope flattens out as TSB approaches a first preselected value for thermal mapping. The slope remains flat until t=10, when the value of Tser again progressively increases as a straight line with a selected slope. At t=13 seconds, TseT again begins to be expressed in term of a nonlinear function, and the slope flattens out as TSeT aPProaches a second preselected value for tissue ablation. In the example shown in Fig. 6B, the first value of Tser for thermal mapping is within 45° C to 50° C, whereas the second value for TsET for tissue ablation is within 50° C to °90 C, and preferable aHout 70 C.
Moreover, TseT can be defined as a true function of time.

In either implementation Fig. 6A or 6B, the DPP 76 receives as input changing values of TsEr over time, which define the prescribed set temperature curve. The system calculates E~L~ based upon these changing values to derive PpE~ND~ in the same manner that the system derives Po~NO based upon a constant value of TsEr.
(c) Adaptive Control System Fig. 7 shows an alternative implantation of the DPP 76, which derives PpEHANn using adaptive control principles. In this implementation, the DPP
76 receives as input Tser and ~Ep in the manner previously described. The values of Tser can be fixed or can vary with time, as also previously described.
In the implementation shown in Fig. 7, the DPP 76 further includes a pair of adaptive filters 78 and 80. Each filter 78 and 80 generates an output based upon an input, expressed in terms of an assumed relationship between them. In the illustrated implementation, the output comprises an estimate, based upon the assumed relationship, of an external condition that can be independently measured by the DPP 76. The DPP 76 compares the estimated output to the actually measured external condition and adjusts the coefficients of the assumed relationship to minimize the error between the two.
In the implementation of the DPP 76 shown in Fig. 7, the filter 78 receives as input the instantaneous power P~t~ applied by the RF source 48 to the ablating electrode 16. The filter 78 generates as output an estimate of the temperature condition TESrtty that the sensing element 30 should sense, given P~L~ and the assumed relationship between P~t~ and the temperature T~t~ at the ablation W O 96f00528 ~ ~~ ;~ ~ ~ ~ ~ PCTIUS95/07960 site. The filter 78 therefore approximates the heat transfer function of the tissue contacting the ablating electrode 16.
The DPP 76 includes a summing junction 82, which derives a temperature error signal TE by subtracting the estimated temperature TESrcc> from the temperature T~t~ actually sensed by the sensing element 30. The DPP 76 feeds back the error signal TE to the filter 78. The filter 78 adjusts the coefficients of the assumed relationship between P~t~
and T~~~to minimize the magnitude of the error TE.
In a preferred implementation, the filter 78 uses a finite linear sequence to express the assumed relationship between P~~~ and T~i~. The I5 sequence estimates a future temperature TESrtt+» based upon present instantaneous power P~L~ and the past power P~t_~~, where n represents the number of past power conditions taken into account. The quantity n can vary according to the accuracy desired.
In an illustrative implementation, the filter 78 takes into account the present power P~t~
and the preceding power P~t_~~ (i.e., n = 1). In this implementation, the finite linear sequence is expressed as follows:
Tssrc e.n=aPfe~+bPft_1 ) where a and b represent the assumed transfer coefficients.
The assumed transfer coefficients comprise initially selected values which are then adjusted to minimize the error signal TE. This adaptive adjustment can be accomplished using various known techniques. For example, the coefficients can be adjusted based upon the Least Mean Square (LMS) method, which tends to minimize the square of the 2194(J71 W096100528 PCTIUS95I019b0 ~.

error TE.
The LMS method updates the coefficients a and b, as follows:
Tett) - Ttt) Tesrtt) apt+t) - act) + ~'PCt)Tett) btt+t) - b<t) + fPtt-t)Tect) where ~t is the step-size of the algorithm.
A larger ~ provides a faster convergence rate but a larger ripple about the optimal coefficients. A smallex ~. reduces both the convergence rate and the ripple about the optimal solution. The optimal value of ~c depends on the characteristics of the system to be modeled. In the case of the illustrated electrode-blood-tissue system, ~ lies in the interval between 0.01 and 0.5.
The filter 80 is the inverse of the filter 78. The filter 80 receives as input a temperature error signal flT generated by the summing junction 84. The summing junction 84 subtracts TpREDICT(t) from Tser to generate the error signal DT.
The filter 80 generates as output DP, which represents an approximation of how much the power Pit) should be altered in view of DT, based upon the inverse of the assumed relationship between power PSt) and temperature Tit) that the filter 78 uses. In the context of the assumed relationship given for the filter 78, the relationship used by the filter 80 can be approximated using a second order Taylor series, as follows:
1 _ b 2b2 OP~tt= a~T~el az~Tt~_t)+ a3 ~T~t-2~
The filter 80 adjusts its coefficients in relation to the adjustments made by the filter 78 to the coefficients a and b, based upon the error signal TE of the summing junction 82, to minimize the . magnitude of this error-signal TE.
The output OP of the filter 80 is fed through another summing junction 86, which is initialized at the outset of the ablation procedure at the beginning power level Po. The summing junction 86 continuously adjusts the beginning power value with the DP output of the inverse filter 80.
The output of the summing junction 86 therefore comprises PpEHAND' The DPP 76 shown in Fig. 7 sends the output PDENAND to the second processing stage 58 to modify Ptt>' (d) Neural Network Prediction Control Because of the particular heat exchange conditions between the tissue and the metallic ablation electrode 16 contacting it, the temperatures measured by the sensing element 30 may not correspond exactly with the actual maximum tissue temperature. This is because the region of hottest temperature occurs beneath the surface of the tissue at a depth of about 0.5 to 1.0 mm from where the energy emitting electrode 16 (and the sensing element 30) contacts the tissue. If the power is applied to heat the tissue too quickly, the actual maximum tissue temperature in this region may exceed 100° C and lead to tissue desiccation.
Fig. 11A shows an alternative embodiment of the DPP 76 which derives PpE~o using neural network control principles. In this implementation, the PTP
70 receiues as input a predicted temperature of the hottest tissue region T~R~tt~ from a neural network predictor 200_ The DPP 76 derives Pp~~tt,» based upon the difference between this T~xPREOICT(t) and Tser ~ The values of TseT can be fixed, or they can vary with time, as previously described. , In this implementation, the predictor 200 comprises a two-layer neural network, although more , hidden layers could be used. The predictor 200 receives as inputs a set of k past samples of temperatures sensed by the element 30 (TM~t_k~t~) . For example, to cover the past two seconds at a sampling period of 0.02 second, k = 100.
The predictor 200 includes a first and second hidden layers and four neurons, designated N~~,x~, where L identifies the layer 1 or 2 and X
identifies a neuron on that layer. The first layer (L=1) has three neurons (X = 1 to 3) , as follows Nct,t>% ~t,zt ; and ~T,3t . The second layer (L=2) comprising one output neuron (X=1), designated N~z,t~.
The weighted past samples of the sensing element 30 TH~L_~~t~ (i = 1 to k) are fed as inputs to each neuron N ; N ; and N of the first layer.
ct,t> ct,z7 ct,3>
Fig. il represents the weighted input samples as W~~k,Ht, where irl; k is the sample order; and N is the input neuron number 1, 2, or 3 of the first layer.
The output neuron N~z,t~ of the second layer receives as inputs the weighted outputs of the neurons N~t,tt; N~t,zt; and ~t,3t . Fig. 11 represents the weighted outputs as W~~o,x~, where L=2; O is the output neuron 1, 2, or 3 of the first layer; and X
is the input neuron number 1 of the second layer.
Based upon these weighted inputs, the output neuron Ntz,t> predicts T~xveeocc>.
The predictor 200- must be trained on a known set of data that have been previously acquired experimentally. For example, using a back-propagation model, the predictor 200 can be trained WO 96100528 - 27 _ - ~ ~ PCT/US95/07960 to predict the known hottest temperature of the data set with the least error. Once the training phase is completed, the predictor 200 can be used to predict T~xPREOCC>-As Fig. 11B shows, the first processing stage 56 can use a single neural network 201 to derive PD~~L~. In this implementation, the network 201 receive as input, in addition to Jc past samples of temperatures from the sensor 30, the value of TSET, and the current power ~t~ . The network 201 derives Pp~Npci~ as output, which reflects the power level required to keep the hottest predicted temperature at or about TSET. As before stated, a set of data containing a solution based upon all the desired inputs is necessary to train the neural network of the predictor 201 to manipulate the input and obtain the desired output with the least amount of error.
(e) Fuszy Logic Control Fig. 12 shows an alternative embodiment of the first processing stage 56 which derives PpE~ND
using fuzzy logic control principles. In this implementation, the first processing stage 56 includes a fuzzifier 202, which receives as inputs the temperature signals TH~t~from the sensor 30. The fuzzifier 202 also receives Ts~ as input, either as a constant value or a value that changes over time.
The fuzzifier 202 converts the TH~t~ input data to fuzzy inputs based upon reference to Tser on a relative basis. For example, the fuzzy inputs can determine the degree (or membership function) to which a given TH~t~ is, compared to ~ , "cool" or T
"warm" or "warmer'° or "hot".
These fuzzy inputs are passed through an I/O mapper 204 which converts them to fuzzy outputs by translating the inputs into descriptive labels of power. This is accomplished, for example, by using linguistic "if... then" rules, like "if the fuzzy input is ... then the fuzzy output is ...."
Alternatively, more complex mapping matricial operators can be used.
For example, if TH~~~ is "cool," the I/O
mapper 204 outputs the descriptive label "Largest-Positive," to indicate that a large relative increase in power is required. By the same token, if TH~t~ is "hot," the I/O mapper 204 outputs the descriptive label "Largest Negative," to indicate that large relative decrease in power is required.
The intermediate fuzzy inputs "warm" and "warmer"
produce intermediate descriptive labels as fuzzy outputs, such as "Smallest Positive" and "Smallest Negative."
These fuzzy outputs are passed through a defuzzifier 206. The defuzzifier 206 also receives actual power P~t~ as an input, since the fuzzy outputs refer to variations in P~t~. Based upon P~L~
and the variations required based upon the fuzzy outputs, the defuzzifier 206 derives PpEMAND(t)~
To finely trim the reference sets and the rules of the I/O mapper 204, it may be required that the fuzzy logic controller be trained on a known set of data before use.
B. The Second Processincr Stage __ In the illustrated and preferred embodiment, the second processing stage 58 (see Fig.
5) includes a converter 112. The converter 112-derives a command voltage signal VoE~NOCt> based upon a power input signal to adjust the amplitude of the voltage V~t~ supplied to the source 48 to thereby adjust P~t~. Alternatively, the converter 112 nould 'NO 96100528 - . PCT/US95/07960 derive a command current signal IDeruaDtt) based upon a power input signal to adjust the amplitude of the current supplied to the source 48, achieving the same results.
(i) The Power Down Stage In one implementation, the power input to the converter 112 could comprise PD~NO(t) as derived by the DPP 76. In the illustrated and preferred embodiment, the second processing stage 58 includes a demand power down stage 94 between the DPP 76 and the converter 112. The power down stage 94 receives PDEMAND(t) as Input and generates a modified demand power signal MPDeMnNDtt)~ taking into account one or more other operating conditions then existing. The converter 112 receives MPD~NO(t) as its input.
More particularly, the power down stage 94 monitors certain operating conditions of the electrode. The power down stage 94 compare the monitored conditions with preselected criteria for 20~ the second operating condition and generate an error signal when the second operating condition fails to meet the preselected criteria. In response to the error signal, the power down stage 94 modifies PDEPIAND(t) in a non-linear fashion t0 set MPDeHaNO(t) at a prescribed low demand power output value P~~. In the absence of the error signal, the power down stage 94 retains the value of PDo(t) as the value of ~DENAND(t)' The value of P« is selected to be above zero, but preferably below the power level at which tissue ablation occurs. In the illustrated and preferred embodiment, P~DW is about 1 watt.
The power down stage 94 sets the value of MfoQUrro(t) in a nonlinear fashion back to the value of 1'DeeuiD(t) as soon as the operating conditions giving rise to the power down mode cease.
In the illustrated and preferred embodiment, the power down stage 94 responds to prescribed power or temperature conditions. Fig. 8 schematically shows a preferred implementation of the power down stage 94.
The power down stage 94 includes microswitches 108 and 110. Microswitch 108 receives as input PpE~o<t~ from the DPP 76 (see Fig. 5, also) .
The microswitch 110 receives as input the value of P~~. An output line 114 connects the converter 112 in parallel to the outputs of the switches 108 and 110.
The power down stage also includes three comparators 114, 116, and 118. Each comparator 114, 116, and 118 independently controls the microswitches 108 and 11a, taking into account different operating conditions.
In the illustrated and preferred embodiment (see Fig. 8), the outputs of the comparators 114, 116, and 118 are connected to OR gate 122. An output switch line S leads to the microswitch 108, while a negate switch line SNec leads to microswitch 110. In the absence of any error signal from any comparator 114, 116, and 118 (when all operating conditions meet prescribed criteria), S = 1 (closing switch 108) and SNE~ = 0 (opening switch 110) . In the presence of an error signal from any comparator 114, 116, and 118 (when at least one operating condition fails to meet prescribed criteria), S = 0 (opening switch 108) and SNE~ = 1 (closing switch 110).
(a) Based Upon Maximum Poxar Conditions The output of the comparator 114 takes into W 0 96f00528 ~ i ~ ~ ~~ 7 ~ PCTIU595107960 account prescribed maximum i:~:~aer conditions. The comparator 114 receives current instantaneously power P~t~ as its (+) input and a prescribed maximum power value P~ as its inverse or (-) input.
In this implementation, the comparator 114 compares P~t~ to the prescribed maximum power value Pte. An error free condition exists when P~t~ < Pte.
In this condition, the comparator 114 sets microswitch 108 closed and microswitch 110 open. In this condition, the microswitch 108 passes through the value of PpEMANOCt~ as the output MPpEMaNOCCW
An error condition exists when P~t~ z P~ .
In this condition, the comparator 114 sets the microswitch 108 open and microswitch 110 closed. In this condition, the microswitch 108 blocks passage of the value of Pp~Npct~, and P~~ becomes the output ~DEIIAND(L)~ In effect, when ~t~ >- ~ , the stage 94 reduces Pp~ND(t) to P~ou in an instantaneous, nonlinear fashion.
The value of PHA can vary according to the particular requirements of the ablation procedure.
The generator 12 can include, as part of its overall interface 13, an interface 96 for the physician to select and adjust P~ (see Fig. 1 also). For cardiac ablation, it is believed that P~ should lie in the range of about 50 watts to about 200 watts, with P~
increasing as the surface area of the ablating electrode increases.
As Fig. 9 shows, the value of PHA can also be set, not upon direct power input settings by the physician, but rather upon the physical and/or functional characteristics of the ablating electrode being used, or both.
The physical and/or functional characteristics of the ablating electrode can WO 96100528 219 4 0 71 pCTIUS95107960 include surface area, electrode -configuration, electrode orientation, and electrode field dispersion properties. For example, an electrode with a smaller surface area can usually be expected to be operated at lower power settings.
The relationships among electrode type and PH~x can be determined by empirical testing. The test results can be transcribed in a look-up power criteria table 102 resident in ROM of the generator 12 (as Fig. 9 shows).
In the preferred embodiment, the power down stage 94A includes a register 98 for automatically setting Pox based upon the power criteria transcribed in the look-up table 102.
The register 98 includes an input 100 (which is part of the overall interface 13 of the generator, as Fig. 1 also shows) for the physician to enter the electrode type being used. The register 98 then automatically sets Pox in the second processing stage 58 based upon the power criteria table 102.
Alternatively (as Fig. 9 also shows), the catheter 14 can itself carry means for automatically producing an identification signal representing the electrode type when the catheter 14 is connected to the generator 12. The signal uniquely identifies the particular physical and/or performance characteristics of the connected electrode 16.
In this arrangement, a data acquisition element 106 queries and reads the identification signal of the catheter 14 to identify the electrode type. The element 106 then refers to the look-up table 102 to automatically set PHAx via the register 98.
The means for automatically generating the TWO 96(00528 PCTIUS95l07960 electrode-type identification signal can vary. Fig.
shows a preferred arrangement.
In tine illustrated embodiment, the catheter handle 20 carries a resistor R having a prescribed 5 ohm value. The ohm value of R represents the sum of calibration resistance value R~A~ (as previously described) and a selected add-on resistance value Rt.
The calibration resistance R~A~ is a fixed value, depending upon the thermistor 34 the catheter 14 10 carries. The magnitude of the add-on value RI varies in predetermined increments depending upon the electrode type.
For example, a Type 1 Electrode is assigned an add-on value RI of 5000 ohms; a Type 2 Electrode is assigned an add-on value RI of 10,000 ohms; a Type 3 Electrode is assigned an add-on value R1 of 15,000 ohms, and so on.
Assuming a fixed calibration resistance R~
for the thermistor 34 used of 4000 ohms, the handle 20 for a Type 1 Electrode will carry a resistor R of 9000 ohms (4000 ohms calibration resistance R~ plus 5000 ohms add-on resistance RI); the handle 20 for a Type 2 Electrode will carry a resistor R of 14,000 ohms (4000 ohms calibration resistance R~ plus 10,000 ohms add-on resistance RI); and the handle 20 for a Type 3 Electrode will carry a resistor R of 19,000 ohms (4000 ohms calibration resistance R~ plus 15,000 ohms add-on resistance RI).
A look-up table 104 in the data acquisition element 106 (shown in Fig. 9) stores tkne fixed value R~ of the calibration resistance, the range of add on resistances RI corresponding to the identified electrode types, and their sum (which is the value of the resistor R that the system actually senses).
When connected to the generator 12 the 2~ 9407 WO 96100528 PCTlUS95107960 element 106 senses the total ohm value of the re-sistor R in the handle 20. -The element 106 refers to the look-up table 104. In the look-up table 104, a sensed total resistance R of less than 10,000 ohms identifies a Type 1 Electrode; a sensed total resistance R of 10,000 ohms to 15,000 ohms iden-tifies a Type 2 Electrode; and a sensed total resistance R of over 15,000 ohms up to 20,000 ohms identifies a Type 3 Electrode.
l0 The element 106 then refers to the power criteria look-up table 102- to obtain the cor-responding power condition. The register 98 automatically sets P~ in the power down stage 94A.
Referring still to the look-up table .104, the data acquisition element 106 subtracts the known add-on value for the identified Electrode Type. In this way, the generator 12 also derives the value of the calibration resistance R~~~ for the thermistor 34. As already described (and as Fig. 5 shows), the first processing stage 56 processes the calibration resistance and the resistance sensed by the thermis-tor to derive the temperature TN~t~, as previously described.
In an alternative embodiment (not shown), instead of the resistor R, the handle can carry a solid state micro-chip, ROM, EEROM, EPROM, or non-volatile RAM.
The micro-chip can be pre-programmed with digital values representing the calibration resis-tance for the thermistor 34 (or the calibration resistances for the multiple thermistors) and the appropriate value representing the Electrode Type.
In this arrangement, the micro-chip outputs these values to the register 98, when queried by the data acquisition element 106.

VN096/00528 ~ PCT1U595/07960 (b) Based upon Maximum Absolute Temp~rature conditions The output of the comparator 116 responds to prescribed maximum absolute temperature conditions. The comparator 116 receives at its (+) input the temperature value TPR~~t~ from the PTP 70.
The comparator 116 receives as its inverse or (-) input a prescribed maximum temperature value T~.
In this implementation, the comparator 116 compares TP~~t~ to the prescribed maximum temperature value T~. An error-free condition exists when TP~~t~ < THE. In this condition, the comparator 116 sets microswitch 108 closed and microswitch 110 open. In this condition, the microswitch 108 passes through the value of PpE~NOCm as the output MPpE~NO:t>.
An error condition exists when TPRm~t~ >_ T~.
In this condition, the comparator 116 sets the microswitch 108 open and microswitch 110 closed. In this condition, the microswitch 108 blocks passage of the value of PoE~o~t), and P~~ becomes the output MPoennuo<W In effect, when TPR~~t~ >_ TAX, the stage 94 reduces Po~ocm to P~~ in an instantaneous, nonlinear fashion.
The value of TAX can be prescribed in various ways. It can, for example, be a selected absolute value that the physician inputs. For cardiac ablation, the value of T~ is believed to lie in the range of 80° C and 95° C, with a preferred representative value of about 90° C.
(c) Based Dpon Incremental Temperature Conditions The output of the comparator 118 responds to prescribed incremental temperature condition TINCR
based upon TsEr~ as follows:

TINCR - Tser + INCR
where INCR is a preselected increment.
The value of INCR can vary, just as Tser can vary, according to the judgment of the physician and empirical data. A representative value of INCR for _ cardiac ablation is believed to lie in the range of 2° C to 8° C, with a preferred representative value of about 5° C.
The comparator 116, like the comparator 114, receives at its (+) input the temperature value TPRm~t~ from the PTP 70. The comparator 116 receives as its inverse or (-) input the prescribed incremental temperature value TINCR~
In this implementation, the comparator 116 compares TP~~L~ to the prescribed incremental temperature value T~NCR. An error-free condition exists when TppED(t) ~ Ttwce ~ In this condition, the comparator 116 sets microswitch 108 closed and microswitch 110 open. In this condition, the microswitch 108 passes through the value of Pp~Npct>
as the output MPpE~NOCt>.
An error condition exists when TPRED(t) ~ Tmce-In this condition, the comparator 116 sets the microswitch 108 open and microswitch 110 closed. In this condition, the microswitch 108 blocks passage of the value of Pp~~oct>, and P~~ becomes the output Mfnsuuoct>~ In effect, when TPRED(t) ~ TINCR~ the stage 94 reduces Pp~ND(t) t~ P~ou in an instantaneous, nonlinear fashion.
(d) Generating Demand Voltage If any comparator 114, 116, or 118 opens switch 108 and closes switch 110 (i.e., when at least one error condition exists), P« is instantaneously set as MPpEpAND(t)~ Under this condition, the converter 112 receives P~~ as VV096I00528 219 4 0 71 PCTlU595/07960 MPDEIUNU(t)~ If none of the comparators 114, 116, or 118 opens switch 108 and closes switch 110, the converter 112 receives PpEU~uocc~ as MPDEauNO(t) The manner in which the converter 112 of the second processing stage 58 generates VpE~ND(t) to adjust P~t~ can vary. For example, the converter 112 can employ proportional control principles, proportional integral derivative (PID) control principles, neural network, fuzzy logic, and adaptive control principles.
In one implementation, the converter 112 employs known PID principles to derive VpE~ND~ In this implementation, the converter 112- compares ~osuuott~ to the generated power signal P~L~, which it receives from the multiplier - 60. In this implementation, the converter 112 also takes into account the changes of the generated power signal P~t~ over time. Based upon these considerations, the converter 112 of the second processing stage 58 derives the demand voltage signal Vp~uo.
Alternatively, the converter 112 can use proportional control principles to directly convert ~uelmott~ to the demand voltage Vp~~uocc>, as follows:
v~rv~ruD c c r - MPn~tuD t a I Z W
where Z~t~ is the sensed impedance of the system and VpE~ct~ is the RMS value of the output voltage.
(e) Monitoring Impedance For this and other purposes, the generator 12 preferably includes an impedance microprocessor 88. The impedance microprocessor 88 receives the WO 96/00528 2 j g 4 0 7 1 PCT/US95107960 instantaneous current signal I~t~ and the instantaneous voltage signal V~t~ from the sensing transformers 62 and 64, already described. The microprocessor 88 derives impedance Z~t~ (in ohms) as follows:
vuo ZteWI
tee Preferably, the generator 12 includes a display 90 as part of its overall interface 13 to show the measured impedance Z~t~ (see Fig. 1 also).
The microprocessor 88 also preferably maintains a record of sampled impedances Z~t~ over time. From this, the microprocessor calculates the changes in impedance during a selected interval and generates appropriate control signals based upon predetermined criteria. Even when the power down stage 94 sets PpE~~(t,~ as ~~ to stop tissue ablation, the microprocessor still serves to continuously compute Z~t~ for the purposes set forth below.
For example, if measured impedance falls outside a predetermined set range, the microprocessor 88 generates a command signal to shut off power to the ablation electrode 16. The set range for impedance for a cardiac ablation procedure is believed to be about 50 to 300 ohms.
When impedance begins in the set range and, over time, increases beyond it, the most likely cause is coagulum formation on the ablation electrode 16. A sudden rise in impedance over the set range suggests the sudden onset of coagulum formation or a sudden shift in the position of the ablation electrode 16. Rapid fluctuations of the impedance also could suggest poor contact between W'0 96100528 PCTIU595/07960 the ablation electrode 16 and the targeted tissue.
All require prompt response; for example, withdrawal and cleaning of the ablation electrode 16, or repositioning of the ablation electrode 16.
The generator 12 preferably includes visual and auditory alarms 92 as part of its overall interface 13 (see Fig. 1 also), to transmit a warning to the user when these impedance-related conditions occur.
A very high impedance value could suggest poor skin contact with the indifferent electrode 18, or an electrical problem in the generator 12.
Again, this calls for prompt corrective action.
(f) Error Shutdown Mode The power down stage 94 rapidly reduces but does not shut down power, based upon prescribed instantaneous high power or high temperature conditions. In the illustrated and preferred embodiment, the second processing stage 58 also includes an error shutdown stage 128. The error shutdown stage 128 responds to the persistence, over a set time period, of a prescribed over-temperature condition or conditions indicative of an actual or developing system failure. The error shutdown phase 126 turns off all power to the electrode 16. The error shutdown phase 128 can work separately from or in tandem with the power down mode.
For example, as long as TPR~~t~ exceeds Tser by an amount less than INCR, the power down stage 94C will not be triggered to set P«. Still, if this over-temperature situation persists for more than a prescribed period of time (for example, 2 to 5 seconds), the second processing stage 58 can be conditioned to assume an actual or developing system failure, and institute a power shutdown.

By way of another example, if TpRED(L) ~ Trux or TINCR~ the power down stage 94B or C will be triggered to set P~~. If this over-temperature situation persists during the power down conditions for a prescribed period of time (for example, 2 to 5 seconds), the second processing stage 58 can be conditioned to assume an actual or developing system failure, and institute a power shutdown.
The generator 12 as described provides control over the ablation procedure. The monitoring and control of power assure the effective distribution of radio frequency energy to the ablation electrode 16, while setting safe physiological limits.
The generator 12can also include an alternative control mode based upon power. In this mode, the generator 12 seeks to maintain a set power condition, independent of measured temperature conditions. The generator 12 would switch to the power control mode, for example, when the electrode 16 in use does not carry a temperature sensing element 30, or upon selection by the physician, even when the electrode 16 has a temperature sensing element 30.
The illustrated and preferred embodiments envision the use of micro-processor controlled components using digital processing to analyze information and generate feedback signals. It should be appreciated that other logic control circuits using micro-switches, AND/OR gates, invertors, and the like are equivalent to the micro-processor controlled components and techniques shown in the preferred embodiments.
Various features of the invention are set forth in the claims that follow.

Claims (17)

CLAIMS:
1. An apparatus for supplying energy to an electrode for ablating tissue comprising a first processing stage to monitor a selected operating condition of the electrode, derive from the monitored operating condition a predicted operating value for a future time (V D), compare the derived predicted operating value for a future time V D to a preselected set operating value (V S) for the operating condition, and establish an error signal (.DELTA.), where:
.DELTA. = V S-V D, and a second processing stage to issue a command signal S COMMAND to adjust power to the electrode above a zero value, thereby maintaining power without interruption, where:
S COMMAND = f(.DELTA.) and where f is a nonlinear function.
2. An apparatus for supplying energy to an electrode for ablating tissue comprising a first processing stage to monitor a selected operating condition of the electrode, derive from the monitored operating condition a predicted operating value for a future time (V D), compare the derived predicted operating value for a future time V D to a preselected set operating value (V S) for the operating condition, and establish an error signal (.DELTA.), where:
.DELTA. = V S-V D, and a second processing stage to issue a command signal S COMMAND to adjust power to the electrode above a zero value, thereby maintaining power without interruption, where:
S COMMAND = f(.DELTA.1, .DELTA.2, .DELTA.3, ...., .DELTA.N) where f is a N-variable nonlinear function that describes the first processing stage and .DELTA.1, .DELTA.2, .DELTA.3, ... ,.DELTA.N are the values of the error signal .DELTA. at N
different moments of time.
3. An apparatus according to claim 1 or 2 wherein V S remains essentially constant over time.
4. An apparatus according to claim 1 or 2 wherein V S changes at least once as a function of time.
5. An apparatus for supplying energy to an electrode for ablating tissue comprising a power source adapted to be electrically coupled to the electrode to supply energy to the electrode for ablating tissue, and a controller coupled to the power source to supply power to the power source, the controller comprising a first processing stage to monitor a selected operating condition, derive from the monitored operating condition an operating value (V
D), compare the derived operating value V D to a preselected set value (V S) for the operating condition, and establish an error signal (.DELTA.), where:
.DELTA. = V S-V D, and a second processing stage to incrementally adjust the power supplied to the electrode according to the following expression:
.DELTA.P = f(S SCALE × .DELTA.) where:
.DELTA.P is the incremental power adjustment;
f is a mathematical function; and S SCALE is a nonlinear scaling factor that equals a first value (X) when .DELTA. > Z and equals a second value (Y), different than X, when .DELTA.
< Z, where Z is a desired .DELTA..
6. An apparatus according to claim 5 wherein Y > X.
7. An apparatus according to claim 5 or 6 wherein Z = 0.
8. An apparatus according to claim 5, further comprising:
a sensing element for measuring temperature at the electrode.
9. An apparatus according to claim 8 wherein the first processing stage monitors changes in temperature measured by the sensing element over time to derive V D.
10. An apparatus according to claim 9 wherein V D comprises a temperature prediction for a future time derived from one or more temperatures measured by the sensing element.
11. An apparatus according to claim 5 wherein V S remains essentially constant over time.
12. An apparatus according to claim 5 wherein V S changes at least once as a function of time.
13. An apparatus for supplying energy to an electrode for ablating tissue comprising a power source adapted to be electrically coupled to the electrode to supply energy to the electrode for ablating tissue, and a controller coupled to the power source to supply power to the power source, the controller comprising a first processing stage to monitor operating conditions and derive a power control signal S DERIVED based upon a first monitored operating condition, and a second processing stage to compare a second monitored operating condition with preselected criteria for the second operating condition, generate an error signal (E) when the second operating condition fails to meet the preselected criteria, and issue a command signal S COMMAND to set power supplied to the power source, wherein, absent the error signal E, S COMMAND sets the power according to S DERIVED, and wherein, when the error signal E is generated, S COMMAND
sets the power at a prescribed low power condition (P LOW), regardless of S
COMMAND, P LOW being a value above zero.
14. An apparatus for supplying energy to an electrode for ablating tissue comprising a power source adapted to be electrically coupled to the electrode to supply energy to the electrode for ablating tissue, and a controller coupled to the power source to supply power to the power source, the controller comprising a first processing stage to monitor operating conditions and derive a power control signal S DERIVED based upon a first monitored operating condition, and a second processing stage to compare a second monitored operating condition with preselected criteria for the second operating condition, generate an error signal (E) when the second operating condition fails to meet the preselected criteria, derive impedance and issue a command signal S COMMAND to set power supplied to the power source, wherein, absent the error signal E, S COMMAND sets the power according to S DERIVED, and wherein, when the error signal E is generated, S COMMAND
sets the power at a prescribed low power condition (P LOW), regardless of S
COMMAND, P LOW being a value above zero to permit derivation of impedance by the second processing stage.
15. An apparatus according to claim 13 or 14 wherein the second monitored operating condition includes a measurement of the power delivered to the power source, and wherein the preselected criteria includes an established maximum power value.
16. An apparatus according to claim 13 or 14 wherein the second monitored operating condition includes a measurement of temperature at the electrode, and wherein the preselected criteria includes an established maximum temperature value.
17. An apparatus according to claim 13 or 14 wherein the second monitored operating condition includes a measurement of temperature at the electrode, and wherein the preselected criteria includes an established set temperature value adjusted by an established incremental value.
CA002194071A 1994-06-27 1995-06-23 Non-linear control systems and methods for heating and ablating body tissue Expired - Fee Related CA2194071C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26602394A 1994-06-27 1994-06-27
US26715494A 1994-06-28 1994-06-28
US08/267,154 1994-06-28
PCT/US1995/007960 WO1996000528A1 (en) 1994-06-27 1995-06-23 Non-linear control systems and methods for heating and ablating body tissue

Publications (2)

Publication Number Publication Date
CA2194071A1 CA2194071A1 (en) 1996-01-11
CA2194071C true CA2194071C (en) 2005-12-13

Family

ID=38657609

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002194071A Expired - Fee Related CA2194071C (en) 1994-06-27 1995-06-23 Non-linear control systems and methods for heating and ablating body tissue

Country Status (8)

Country Link
US (2) US5755715A (en)
EP (1) EP0767628B1 (en)
JP (1) JP3682066B2 (en)
AT (1) ATE257675T1 (en)
CA (1) CA2194071C (en)
DE (1) DE69532447T2 (en)
ES (1) ES2216016T3 (en)
WO (2) WO1996000040A1 (en)

Families Citing this family (307)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906614A (en) * 1991-11-08 1999-05-25 Ep Technologies, Inc. Tissue heating and ablation systems and methods using predicted temperature for monitoring and control
US6113591A (en) * 1994-06-27 2000-09-05 Ep Technologies, Inc. Systems and methods for sensing sub-surface temperatures in body tissue
US6053912A (en) * 1995-05-01 2000-04-25 Ep Techonologies, Inc. Systems and methods for sensing sub-surface temperatures in body tissue during ablation with actively cooled electrodes
US6030379A (en) * 1995-05-01 2000-02-29 Ep Technologies, Inc. Systems and methods for seeking sub-surface temperature conditions during tissue ablation
US5837001A (en) * 1995-12-08 1998-11-17 C. R. Bard Radio frequency energy delivery system for multipolar electrode catheters
US5665103A (en) * 1996-03-07 1997-09-09 Scimed Life Systems, Inc. Stent locating device
US5755760A (en) * 1996-03-11 1998-05-26 Medtronic, Inc. Deflectable catheter
EP0847729A1 (en) * 1996-12-12 1998-06-17 Sulzer Osypka GmbH Ablation device for intracardiac heart treatment
US6063078A (en) * 1997-03-12 2000-05-16 Medtronic, Inc. Method and apparatus for tissue ablation
US6634363B1 (en) 1997-04-07 2003-10-21 Broncus Technologies, Inc. Methods of treating lungs having reversible obstructive pulmonary disease
US7992572B2 (en) 1998-06-10 2011-08-09 Asthmatx, Inc. Methods of evaluating individuals having reversible obstructive pulmonary disease
US7027869B2 (en) 1998-01-07 2006-04-11 Asthmatx, Inc. Method for treating an asthma attack
US6024740A (en) 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US6012457A (en) 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US5971983A (en) 1997-05-09 1999-10-26 The Regents Of The University Of California Tissue ablation device and method of use
US6164283A (en) 1997-07-08 2000-12-26 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6997925B2 (en) * 1997-07-08 2006-02-14 Atrionx, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6514249B1 (en) 1997-07-08 2003-02-04 Atrionix, Inc. Positioning system and method for orienting an ablation element within a pulmonary vein ostium
US6652515B1 (en) * 1997-07-08 2003-11-25 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6500174B1 (en) * 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6245064B1 (en) 1997-07-08 2001-06-12 Atrionix, Inc. Circumferential ablation device assembly
US6007532A (en) * 1997-08-29 1999-12-28 3M Innovative Properties Company Method and apparatus for detecting loss of contact of biomedical electrodes with patient skin
US6165173A (en) * 1997-10-06 2000-12-26 Somnus Medical Technologies, Inc. Memory for regulating device utilization and behavior
US6464699B1 (en) 1997-10-10 2002-10-15 Scimed Life Systems, Inc. Method and apparatus for positioning a diagnostic or therapeutic element on body tissue and mask element for use with same
US6645200B1 (en) 1997-10-10 2003-11-11 Scimed Life Systems, Inc. Method and apparatus for positioning a diagnostic or therapeutic element within the body and tip electrode for use with same
DE69840602D1 (en) * 1997-10-23 2009-04-09 Arthrocare Corp ENERGY SUPPLY FOR ELECTRO-SURGERY IN CONDUCTIVE FLUIDS
US7921855B2 (en) 1998-01-07 2011-04-12 Asthmatx, Inc. Method for treating an asthma attack
US6558378B2 (en) * 1998-05-05 2003-05-06 Cardiac Pacemakers, Inc. RF ablation system and method having automatic temperature control
US6837885B2 (en) 1998-05-22 2005-01-04 Scimed Life Systems, Inc. Surgical probe for supporting inflatable therapeutic devices in contact with tissue in or around body orifices and within tumors
US8181656B2 (en) 1998-06-10 2012-05-22 Asthmatx, Inc. Methods for treating airways
US7198635B2 (en) 2000-10-17 2007-04-03 Asthmatx, Inc. Modification of airways by application of energy
US6123702A (en) * 1998-09-10 2000-09-26 Scimed Life Systems, Inc. Systems and methods for controlling power in an electrosurgical probe
WO2000015130A2 (en) 1998-09-10 2000-03-23 Scimed Life Systems, Inc. Systems for controlling an ablation process performed with a heart electrocatheter
US6245065B1 (en) 1998-09-10 2001-06-12 Scimed Life Systems, Inc. Systems and methods for controlling power in an electrosurgical probe
US6183468B1 (en) 1998-09-10 2001-02-06 Scimed Life Systems, Inc. Systems and methods for controlling power in an electrosurgical probe
US7137980B2 (en) 1998-10-23 2006-11-21 Sherwood Services Ag Method and system for controlling output of RF medical generator
US7901400B2 (en) * 1998-10-23 2011-03-08 Covidien Ag Method and system for controlling output of RF medical generator
US7364577B2 (en) 2002-02-11 2008-04-29 Sherwood Services Ag Vessel sealing system
US6607502B1 (en) 1998-11-25 2003-08-19 Atrionix, Inc. Apparatus and method incorporating an ultrasound transducer onto a delivery member
US6702265B1 (en) 1999-02-10 2004-03-09 Erik Zapletal Balanced suspension system
US6217528B1 (en) 1999-02-11 2001-04-17 Scimed Life Systems, Inc. Loop structure having improved tissue contact capability
US6758830B1 (en) 1999-05-11 2004-07-06 Atrionix, Inc. Catheter positioning system
ES2279757T3 (en) 1999-05-11 2007-09-01 Atrionix, Inc. BALL ANCHORING THREAD.
US6402741B1 (en) * 1999-10-08 2002-06-11 Sherwood Services Ag Current and status monitor
EP1233716B1 (en) 1999-11-22 2014-07-30 Boston Scientific Limited Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue
US6645199B1 (en) 1999-11-22 2003-11-11 Scimed Life Systems, Inc. Loop structures for supporting diagnostic and therapeutic elements contact with body tissue and expandable push devices for use with same
US7097641B1 (en) 1999-12-09 2006-08-29 Cryocath Technologies Inc. Catheter with cryogenic and heating ablation
US6689131B2 (en) 2001-03-08 2004-02-10 Tissuelink Medical, Inc. Electrosurgical device having a tissue reduction sensor
US7811282B2 (en) 2000-03-06 2010-10-12 Salient Surgical Technologies, Inc. Fluid-assisted electrosurgical devices, electrosurgical unit with pump and methods of use thereof
US6558385B1 (en) 2000-09-22 2003-05-06 Tissuelink Medical, Inc. Fluid-assisted medical device
US8048070B2 (en) 2000-03-06 2011-11-01 Salient Surgical Technologies, Inc. Fluid-assisted medical devices, systems and methods
ES2306706T3 (en) 2000-03-06 2008-11-16 Salient Surgical Technologies, Inc. FLUID SUPPLY SYSTEM AND CONTROLLER FOR ELECTROCHURGICAL DEVICES.
US8251070B2 (en) 2000-03-27 2012-08-28 Asthmatx, Inc. Methods for treating airways
CA2405348A1 (en) 2000-04-13 2001-11-01 Ocean Spray Cranberries, Inc. Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor
AU2001249874A1 (en) 2000-04-27 2001-11-12 Medtronic, Inc. System and method for assessing transmurality of ablation lesions
US6599288B2 (en) 2000-05-16 2003-07-29 Atrionix, Inc. Apparatus and method incorporating an ultrasound transducer onto a delivery member
DE60109444T2 (en) 2000-06-13 2006-04-13 Atrionix, Inc., Irwindale SURGICAL ABLATION PROBE FOR FORMING A RINGED LESION
US6942661B2 (en) 2000-08-30 2005-09-13 Boston Scientific Scimed, Inc. Fluid cooled apparatus for supporting diagnostic and therapeutic elements in contact with tissue
US7104987B2 (en) * 2000-10-17 2006-09-12 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US6827714B2 (en) 2001-03-07 2004-12-07 Scimed Life Systems, Inc. Internal indifferent electrode device for use with lesion creation apparatus and method of forming lesions using the same
US20030040670A1 (en) * 2001-06-15 2003-02-27 Assaf Govari Method for measuring temperature and of adjusting for temperature sensitivity with a medical device having a position sensor
CA2453410A1 (en) * 2001-07-27 2003-02-13 Wit Ip Corporation Methods for treating prostatitis
US7785324B2 (en) 2005-02-25 2010-08-31 Endoscopic Technologies, Inc. (Estech) Clamp based lesion formation apparatus and methods configured to protect non-target tissue
US7674258B2 (en) 2002-09-24 2010-03-09 Endoscopic Technologies, Inc. (ESTECH, Inc.) Electrophysiology electrode having multiple power connections and electrophysiology devices including the same
US7753908B2 (en) 2002-02-19 2010-07-13 Endoscopic Technologies, Inc. (Estech) Apparatus for securing an electrophysiology probe to a clamp
US20030158548A1 (en) 2002-02-19 2003-08-21 Phan Huy D. Surgical system including clamp and apparatus for securing an energy transmission device to the clamp and method of converting a clamp into an electrophysiology device
US6932816B2 (en) * 2002-02-19 2005-08-23 Boston Scientific Scimed, Inc. Apparatus for converting a clamp into an electrophysiology device
US7258688B1 (en) 2002-04-16 2007-08-21 Baylis Medical Company Inc. Computerized electrical signal generator
US7008417B2 (en) 2002-04-22 2006-03-07 Medtronics, Inc. Detecting coagulum formation
ES2289307T3 (en) 2002-05-06 2008-02-01 Covidien Ag BLOOD DETECTOR TO CONTROL AN ELECTROCHIRURGICAL UNIT.
US6786202B2 (en) * 2002-09-24 2004-09-07 Caterpillar Inc Hydraulic pump circuit
EP1572020A4 (en) 2002-10-29 2006-05-03 Tissuelink Medical Inc Fluid-assisted electrosurgical scissors and methods
US7044948B2 (en) 2002-12-10 2006-05-16 Sherwood Services Ag Circuit for controlling arc energy from an electrosurgical generator
US7131445B2 (en) * 2002-12-23 2006-11-07 Gyrus Medical Limited Electrosurgical method and apparatus
US20040158237A1 (en) * 2003-02-11 2004-08-12 Marwan Abboud Multi-energy ablation station
US7357800B2 (en) * 2003-02-14 2008-04-15 Boston Scientific Scimed, Inc. Power supply and control apparatus and electrophysiology systems including the same
US7909820B2 (en) * 2003-03-06 2011-03-22 Salient Surgical Technologies, Inc. Electrosurgical generator and bipolar electrosurgical device adaptors
WO2004083797A2 (en) * 2003-03-14 2004-09-30 Thermosurgery Technologies, Inc. Hyperthermia treatment system
US20040186467A1 (en) * 2003-03-21 2004-09-23 Swanson David K. Apparatus for maintaining contact between diagnostic and therapeutic elements and tissue and systems including the same
EP1617776B1 (en) 2003-05-01 2015-09-02 Covidien AG System for programing and controlling an electrosurgical generator system
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
DE202004021943U1 (en) 2003-09-12 2013-05-13 Vessix Vascular, Inc. Selectable eccentric remodeling and / or ablation of atherosclerotic material
US7435248B2 (en) * 2003-09-26 2008-10-14 Boston Scientific Scimed, Inc. Medical probes for creating and diagnosing circumferential lesions within or around the ostium of a vessel
US8104956B2 (en) 2003-10-23 2012-01-31 Covidien Ag Thermocouple measurement circuit
EP2258294B1 (en) 2003-10-23 2013-01-09 Covidien AG Redundant temperature monitoring in electrosurgical systems for safety mitigation
US7396336B2 (en) 2003-10-30 2008-07-08 Sherwood Services Ag Switched resonant ultrasonic power amplifier system
US7131860B2 (en) 2003-11-20 2006-11-07 Sherwood Services Ag Connector systems for electrosurgical generator
US7300435B2 (en) * 2003-11-21 2007-11-27 Sherwood Services Ag Automatic control system for an electrosurgical generator
US8002770B2 (en) 2003-12-02 2011-08-23 Endoscopic Technologies, Inc. (Estech) Clamp based methods and apparatus for forming lesions in tissue and confirming whether a therapeutic lesion has been formed
US7608072B2 (en) 2003-12-02 2009-10-27 Boston Scientific Scimed, Inc. Surgical methods and apparatus for maintaining contact between tissue and electrophysiology elements and confirming whether a therapeutic lesion has been formed
US8052676B2 (en) * 2003-12-02 2011-11-08 Boston Scientific Scimed, Inc. Surgical methods and apparatus for stimulating tissue
US7727232B1 (en) 2004-02-04 2010-06-01 Salient Surgical Technologies, Inc. Fluid-assisted medical devices and methods
US7766905B2 (en) 2004-02-12 2010-08-03 Covidien Ag Method and system for continuity testing of medical electrodes
US7780662B2 (en) 2004-03-02 2010-08-24 Covidien Ag Vessel sealing system using capacitive RF dielectric heating
EP1778330B1 (en) 2004-08-20 2020-10-07 Fisher & Paykel Healthcare Limited Apparatus for measuring properties of gases supplied to a patient
US7549988B2 (en) 2004-08-30 2009-06-23 Boston Scientific Scimed, Inc. Hybrid lesion formation apparatus, systems and methods
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
US7628786B2 (en) 2004-10-13 2009-12-08 Covidien Ag Universal foot switch contact port
US8409191B2 (en) 2004-11-04 2013-04-02 Boston Scientific Scimed, Inc. Preshaped ablation catheter for ablating pulmonary vein ostia within the heart
JP2006180936A (en) * 2004-12-24 2006-07-13 Olympus Medical Systems Corp Heating treatment device
US7862561B2 (en) * 2005-01-08 2011-01-04 Boston Scientific Scimed, Inc. Clamp based lesion formation apparatus with variable spacing structures
US7727231B2 (en) 2005-01-08 2010-06-01 Boston Scientific Scimed, Inc. Apparatus and methods for forming lesions in tissue and applying stimulation energy to tissue in which lesions are formed
US7776033B2 (en) * 2005-01-08 2010-08-17 Boston Scientific Scimed, Inc. Wettable structures including conductive fibers and apparatus including the same
US7114197B2 (en) * 2005-01-14 2006-10-03 Louis Garneau Sport Inc. Adjustable stabilization strap apparatus
US7862562B2 (en) * 2005-02-25 2011-01-04 Boston Scientific Scimed, Inc. Wrap based lesion formation apparatus and methods configured to protect non-target tissue
US9474564B2 (en) 2005-03-31 2016-10-25 Covidien Ag Method and system for compensating for external impedance of an energy carrying component when controlling an electrosurgical generator
EP1874211B1 (en) 2005-04-21 2017-05-31 Boston Scientific Scimed, Inc. Control devices for energy delivery
US20060247522A1 (en) * 2005-04-28 2006-11-02 Boston Scientific Scimed, Inc. Magnetic navigation systems with dynamic mechanically manipulatable catheters
US9320564B2 (en) * 2005-05-05 2016-04-26 Boston Scientific Scimed Inc. Steerable catheter and method for performing medical procedure adjacent pulmonary vein ostia
US7442190B2 (en) 2005-05-13 2008-10-28 Cryocath Technologies Inc. Contact assessment of balloon catheters
US8932208B2 (en) 2005-05-26 2015-01-13 Maquet Cardiovascular Llc Apparatus and methods for performing minimally-invasive surgical procedures
US8016822B2 (en) * 2005-05-28 2011-09-13 Boston Scientific Scimed, Inc. Fluid injecting devices and methods and apparatus for maintaining contact between fluid injecting devices and tissue
US7655003B2 (en) 2005-06-22 2010-02-02 Smith & Nephew, Inc. Electrosurgical power control
US8945151B2 (en) * 2005-07-13 2015-02-03 Atricure, Inc. Surgical clip applicator and apparatus including the same
US8721634B2 (en) * 2005-07-21 2014-05-13 Covidien Lp Apparatus and method for ensuring thermal treatment of a hollow anatomical structure
US20070073286A1 (en) * 2005-09-29 2007-03-29 Dorin Panescu Method and apparatus for an ocular procedure
US8734438B2 (en) 2005-10-21 2014-05-27 Covidien Ag Circuit and method for reducing stored energy in an electrosurgical generator
US8696656B2 (en) 2005-11-18 2014-04-15 Medtronic Cryocath Lp System and method for monitoring bioimpedance and respiration
US7842031B2 (en) * 2005-11-18 2010-11-30 Medtronic Cryocath Lp Bioimpedance measurement system and method
US10362959B2 (en) 2005-12-06 2019-07-30 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing the proximity of an electrode to tissue in a body
CA2631940C (en) 2005-12-06 2016-06-21 St. Jude Medical, Atrial Fibrillation Division, Inc. Assessment of electrode coupling for tissue ablation
US9254163B2 (en) 2005-12-06 2016-02-09 St. Jude Medical, Atrial Fibrillation Division, Inc. Assessment of electrode coupling for tissue ablation
US20090177111A1 (en) * 2006-12-06 2009-07-09 Miller Stephan P System and method for displaying contact between a catheter and tissue
US8998890B2 (en) 2005-12-06 2015-04-07 St. Jude Medical, Atrial Fibrillation Division, Inc. Assessment of electrode coupling for tissue ablation
US8403925B2 (en) 2006-12-06 2013-03-26 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing lesions in tissue
US9492226B2 (en) 2005-12-06 2016-11-15 St. Jude Medical, Atrial Fibrillation Division, Inc. Graphical user interface for real-time RF lesion depth display
US8603084B2 (en) 2005-12-06 2013-12-10 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing the formation of a lesion in tissue
US8406866B2 (en) 2005-12-06 2013-03-26 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing coupling between an electrode and tissue
US7947039B2 (en) 2005-12-12 2011-05-24 Covidien Ag Laparoscopic apparatus for performing electrosurgical procedures
US8876746B2 (en) 2006-01-06 2014-11-04 Arthrocare Corporation Electrosurgical system and method for treating chronic wound tissue
BRPI0706605B8 (en) 2006-01-17 2021-06-22 Endymed Medical Ltd electrosurgical system employing phase-controlled radiofrequency energy
US9186200B2 (en) 2006-01-24 2015-11-17 Covidien Ag System and method for tissue sealing
US8685016B2 (en) 2006-01-24 2014-04-01 Covidien Ag System and method for tissue sealing
US8147485B2 (en) 2006-01-24 2012-04-03 Covidien Ag System and method for tissue sealing
EP3210557B1 (en) 2006-01-24 2018-10-17 Covidien AG System for tissue sealing
US7513896B2 (en) 2006-01-24 2009-04-07 Covidien Ag Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling
CA2574934C (en) 2006-01-24 2015-12-29 Sherwood Services Ag System and method for closed loop monitoring of monopolar electrosurgical apparatus
CA2574935A1 (en) 2006-01-24 2007-07-24 Sherwood Services Ag A method and system for controlling an output of a radio-frequency medical generator having an impedance based control algorithm
US8216223B2 (en) 2006-01-24 2012-07-10 Covidien Ag System and method for tissue sealing
US7651493B2 (en) 2006-03-03 2010-01-26 Covidien Ag System and method for controlling electrosurgical snares
US7648499B2 (en) 2006-03-21 2010-01-19 Covidien Ag System and method for generating radio frequency energy
US7651492B2 (en) 2006-04-24 2010-01-26 Covidien Ag Arc based adaptive control system for an electrosurgical unit
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
US8753334B2 (en) 2006-05-10 2014-06-17 Covidien Ag System and method for reducing leakage current in an electrosurgical generator
EP2037840B2 (en) 2006-06-28 2019-02-20 Medtronic Ardian Luxembourg S.à.r.l. Systems for thermally-induced renal neuromodulation
US7731717B2 (en) 2006-08-08 2010-06-08 Covidien Ag System and method for controlling RF output during tissue sealing
US8034049B2 (en) 2006-08-08 2011-10-11 Covidien Ag System and method for measuring initial tissue impedance
US7794457B2 (en) 2006-09-28 2010-09-14 Covidien Ag Transformer for RF voltage sensing
WO2008049087A2 (en) 2006-10-18 2008-04-24 Minnow Medical, Inc. System for inducing desirable temperature effects on body tissue
EP2954868A1 (en) 2006-10-18 2015-12-16 Vessix Vascular, Inc. Tuned rf energy and electrical tissue characterization for selective treatment of target tissues
WO2008049082A2 (en) 2006-10-18 2008-04-24 Minnow Medical, Inc. Inducing desirable temperature effects on body tissue
GB2452103B (en) 2007-01-05 2011-08-31 Arthrocare Corp Electrosurgical system with suction control apparatus and system
WO2008125962A2 (en) * 2007-03-01 2008-10-23 Endymed Medical Ltd. Electrosurgical methods and devices employing semiconductor chips
US8777941B2 (en) 2007-05-10 2014-07-15 Covidien Lp Adjustable impedance electrosurgical electrodes
US7834484B2 (en) 2007-07-16 2010-11-16 Tyco Healthcare Group Lp Connection cable and method for activating a voltage-controlled generator
US9403029B2 (en) 2007-07-18 2016-08-02 Visualase, Inc. Systems and methods for thermal therapy
WO2009015278A1 (en) * 2007-07-24 2009-01-29 Asthmatx, Inc. System and method for controlling power based on impedance detection, such as controlling power to tissue treatment devices
WO2009029523A1 (en) * 2007-08-24 2009-03-05 Boston Scientific Scimed, Inc. Magnetically steerable catheter assembly
US8216220B2 (en) 2007-09-07 2012-07-10 Tyco Healthcare Group Lp System and method for transmission of combined data stream
US8512332B2 (en) 2007-09-21 2013-08-20 Covidien Lp Real-time arc control in electrosurgical generators
WO2009045265A1 (en) 2007-10-05 2009-04-09 Maquet Cardiovascular, Llc Devices and methods for minimally-invasive surgical procedures
US8290578B2 (en) 2007-12-28 2012-10-16 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and apparatus for complex impedance compensation
US9204927B2 (en) 2009-05-13 2015-12-08 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for presenting information representative of lesion formation in tissue during an ablation procedure
US9358063B2 (en) 2008-02-14 2016-06-07 Arthrocare Corporation Ablation performance indicator for electrosurgical devices
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US8257349B2 (en) * 2008-03-28 2012-09-04 Tyco Healthcare Group Lp Electrosurgical apparatus with predictive RF source control
WO2009124097A1 (en) 2008-03-31 2009-10-08 Applied Medical Resources Corporation Electrosurgical system
AU2009244058B2 (en) 2008-05-09 2015-07-02 Nuvaira, Inc Systems, assemblies, and methods for treating a bronchial tree
US8226639B2 (en) 2008-06-10 2012-07-24 Tyco Healthcare Group Lp System and method for output control of electrosurgical generator
DE102008050635A1 (en) * 2008-10-07 2010-04-15 Erbe Elektromedizin Gmbh Method and apparatus for controlling a cooled RF ablation probe
EP2355737B1 (en) 2008-11-17 2021-08-11 Boston Scientific Scimed, Inc. Selective accumulation of energy without knowledge of tissue topography
US8900150B2 (en) 2008-12-30 2014-12-02 St. Jude Medical, Atrial Fibrillation Division, Inc. Intracardiac imaging system utilizing a multipurpose catheter
US9610118B2 (en) 2008-12-31 2017-04-04 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and apparatus for the cancellation of motion artifacts in medical interventional navigation
US8262652B2 (en) 2009-01-12 2012-09-11 Tyco Healthcare Group Lp Imaginary impedance process monitoring and intelligent shut-off
US9226791B2 (en) 2012-03-12 2016-01-05 Advanced Cardiac Therapeutics, Inc. Systems for temperature-controlled ablation using radiometric feedback
US8954161B2 (en) 2012-06-01 2015-02-10 Advanced Cardiac Therapeutics, Inc. Systems and methods for radiometrically measuring temperature and detecting tissue contact prior to and during tissue ablation
US8926605B2 (en) 2012-02-07 2015-01-06 Advanced Cardiac Therapeutics, Inc. Systems and methods for radiometrically measuring temperature during tissue ablation
US9277961B2 (en) 2009-06-12 2016-03-08 Advanced Cardiac Therapeutics, Inc. Systems and methods of radiometrically determining a hot-spot temperature of tissue being treated
US8257350B2 (en) 2009-06-17 2012-09-04 Arthrocare Corporation Method and system of an electrosurgical controller with wave-shaping
US8388614B2 (en) 2009-09-29 2013-03-05 Covidien Lp Return electrode temperature prediction
CN107049479B (en) 2009-10-27 2020-10-16 努瓦拉公司 Delivery device with coolable energy emitting assembly
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
JP6000851B2 (en) 2009-11-11 2016-10-05 ホライラ, インコーポレイテッド Systems, devices, and methods for tissue treatment and stenosis control
US8372067B2 (en) 2009-12-09 2013-02-12 Arthrocare Corporation Electrosurgery irrigation primer systems and methods
US20110172659A1 (en) * 2010-01-13 2011-07-14 Vivant Medical, Inc. Ablation Device With User Interface at Device Handle, System Including Same, and Method of Ablating Tissue Using Same
JP2013523318A (en) 2010-04-09 2013-06-17 べシックス・バスキュラー・インコーポレイテッド Power generation and control equipment for tissue treatment
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US8840609B2 (en) 2010-07-23 2014-09-23 Conmed Corporation Tissue fusion system and method of performing a functional verification test
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9463062B2 (en) 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
EP2898846B1 (en) 2010-10-01 2018-01-31 Applied Medical Resources Corporation Electrosurgical system with a radio frequency amplifier and with means for adaptation to electrode spacing
EP2632373B1 (en) 2010-10-25 2018-07-18 Medtronic Ardian Luxembourg S.à.r.l. System for evaluation and feedback of neuromodulation treatment
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9326751B2 (en) 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
US9737353B2 (en) * 2010-12-16 2017-08-22 Biosense Webster (Israel) Ltd. System for controlling tissue ablation using temperature sensors
WO2012100095A1 (en) 2011-01-19 2012-07-26 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
US9131597B2 (en) 2011-02-02 2015-09-08 Arthrocare Corporation Electrosurgical system and method for treating hard body tissue
US9579030B2 (en) 2011-07-20 2017-02-28 Boston Scientific Scimed, Inc. Percutaneous devices and methods to visualize, target and ablate nerves
CN103813829B (en) 2011-07-22 2016-05-18 波士顿科学西美德公司 There is the neuromodulation system of the neuromodulation element that can be positioned in spiral guiding piece
US10201385B2 (en) 2011-09-01 2019-02-12 Biosense Webster (Israel) Ltd. Catheter adapted for direct tissue contact
US8900228B2 (en) 2011-09-01 2014-12-02 Biosense Webster (Israel) Ltd. Catheter adapted for direct tissue contact and pressure sensing
US9186210B2 (en) 2011-10-10 2015-11-17 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
US10085799B2 (en) 2011-10-11 2018-10-02 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
WO2013059202A1 (en) 2011-10-18 2013-04-25 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
US9162046B2 (en) 2011-10-18 2015-10-20 Boston Scientific Scimed, Inc. Deflectable medical devices
EP3366250A1 (en) 2011-11-08 2018-08-29 Boston Scientific Scimed, Inc. Ostial renal nerve ablation
US9119600B2 (en) 2011-11-15 2015-09-01 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
JP6130397B2 (en) 2011-12-23 2017-05-17 べシックス・バスキュラー・インコーポレイテッド Device for remodeling tissue in or adjacent to a body passage
WO2013101452A1 (en) 2011-12-28 2013-07-04 Boston Scientific Scimed, Inc. Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
US9375250B2 (en) 2012-04-09 2016-06-28 Covidien Lp Method for employing single fault safe redundant signals
WO2013169927A1 (en) 2012-05-08 2013-11-14 Boston Scientific Scimed, Inc. Renal nerve modulation devices
WO2013184319A1 (en) 2012-06-04 2013-12-12 Boston Scientific Scimed, Inc. Systems and methods for treating tissue of a passageway within a body
EP2877113B1 (en) 2012-07-24 2018-07-25 Boston Scientific Scimed, Inc. Electrodes for tissue treatment
WO2014032016A1 (en) 2012-08-24 2014-02-27 Boston Scientific Scimed, Inc. Intravascular catheter with a balloon comprising separate microporous regions
WO2014043687A2 (en) 2012-09-17 2014-03-20 Boston Scientific Scimed, Inc. Self-positioning electrode system and method for renal nerve modulation
WO2014047454A2 (en) 2012-09-21 2014-03-27 Boston Scientific Scimed, Inc. Self-cooling ultrasound ablation catheter
US10398464B2 (en) 2012-09-21 2019-09-03 Boston Scientific Scimed, Inc. System for nerve modulation and innocuous thermal gradient nerve block
EP2906135A2 (en) 2012-10-10 2015-08-19 Boston Scientific Scimed, Inc. Renal nerve modulation devices and methods
US9272132B2 (en) 2012-11-02 2016-03-01 Boston Scientific Scimed, Inc. Medical device for treating airways and related methods of use
WO2014071372A1 (en) 2012-11-05 2014-05-08 Boston Scientific Scimed, Inc. Devices for delivering energy to body lumens
US9445725B2 (en) 2012-12-17 2016-09-20 Biosense Webster (Israel) Ltd. Irrigated catheter tip with temperature sensor array
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9693818B2 (en) 2013-03-07 2017-07-04 Arthrocare Corporation Methods and systems related to electrosurgical wands
US9713489B2 (en) 2013-03-07 2017-07-25 Arthrocare Corporation Electrosurgical methods and systems
WO2014163987A1 (en) 2013-03-11 2014-10-09 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9693821B2 (en) 2013-03-11 2017-07-04 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9801678B2 (en) 2013-03-13 2017-10-31 Arthrocare Corporation Method and system of controlling conductive fluid flow during an electrosurgical procedure
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
US9703317B2 (en) 2013-03-14 2017-07-11 Biosense Webster (Israel) Ltd. Dongle with shape memory
US10265122B2 (en) 2013-03-15 2019-04-23 Boston Scientific Scimed, Inc. Nerve ablation devices and related methods of use
JP6220044B2 (en) 2013-03-15 2017-10-25 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device for renal nerve ablation
WO2014149690A2 (en) 2013-03-15 2014-09-25 Boston Scientific Scimed, Inc. Medical devices and methods for treatment of hypertension that utilize impedance compensation
US9504516B2 (en) 2013-05-31 2016-11-29 Covidien LLP Gain compensation for a full bridge inverter
US10022182B2 (en) 2013-06-21 2018-07-17 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation having rotatable shafts
CN105473091B (en) 2013-06-21 2020-01-21 波士顿科学国际有限公司 Renal denervation balloon catheter with co-movable electrode supports
US9707036B2 (en) 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
WO2015002787A1 (en) 2013-07-01 2015-01-08 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
US10660698B2 (en) 2013-07-11 2020-05-26 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation
WO2015006573A1 (en) 2013-07-11 2015-01-15 Boston Scientific Scimed, Inc. Medical device with stretchable electrode assemblies
US9925001B2 (en) 2013-07-19 2018-03-27 Boston Scientific Scimed, Inc. Spiral bipolar electrode renal denervation balloon
US10342609B2 (en) 2013-07-22 2019-07-09 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
CN105392435B (en) 2013-07-22 2018-11-09 波士顿科学国际有限公司 Renal nerve ablation catheter with twisting sacculus
US9872719B2 (en) 2013-07-24 2018-01-23 Covidien Lp Systems and methods for generating electrosurgical energy using a multistage power converter
US9655670B2 (en) 2013-07-29 2017-05-23 Covidien Lp Systems and methods for measuring tissue impedance through an electrosurgical cable
JP5816774B2 (en) * 2013-08-02 2015-11-18 オリンパス株式会社 Biological tissue joining system, treatment instrument control device, and operating method of biological tissue joining system
CN105451680B (en) 2013-08-09 2019-10-08 波士顿科学国际有限公司 The correlation technique of expansible conduit and manufacture and use
EP4049605A1 (en) 2013-08-22 2022-08-31 Boston Scientific Scimed Inc. Flexible circuit having improved adhesion to a renal nerve modulation balloon
WO2015035047A1 (en) 2013-09-04 2015-03-12 Boston Scientific Scimed, Inc. Radio frequency (rf) balloon catheter having flushing and cooling capability
EP3043733A1 (en) 2013-09-13 2016-07-20 Boston Scientific Scimed, Inc. Ablation balloon with vapor deposited cover layer
US11246654B2 (en) 2013-10-14 2022-02-15 Boston Scientific Scimed, Inc. Flexible renal nerve ablation devices and related methods of use and manufacture
US9687166B2 (en) 2013-10-14 2017-06-27 Boston Scientific Scimed, Inc. High resolution cardiac mapping electrode array catheter
WO2015057584A1 (en) 2013-10-15 2015-04-23 Boston Scientific Scimed, Inc. Medical device balloon
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
EP3057521B1 (en) 2013-10-18 2020-03-25 Boston Scientific Scimed, Inc. Balloon catheters with flexible conducting wires
US10433902B2 (en) 2013-10-23 2019-10-08 Medtronic Ardian Luxembourg S.A.R.L. Current control methods and systems
EP3060153A1 (en) 2013-10-25 2016-08-31 Boston Scientific Scimed, Inc. Embedded thermocouple in denervation flex circuit
WO2015066164A1 (en) 2013-10-31 2015-05-07 Boston Scientific Scimed, Inc. Medical device for high resolution mapping using localized matching
US10076258B2 (en) 2013-11-01 2018-09-18 Boston Scientific Scimed, Inc. Cardiac mapping using latency interpolation
CN105899157B (en) 2014-01-06 2019-08-09 波士顿科学国际有限公司 Tear-proof flexible circuit assembly
US11000679B2 (en) 2014-02-04 2021-05-11 Boston Scientific Scimed, Inc. Balloon protection and rewrapping devices and related methods of use
EP3102136B1 (en) 2014-02-04 2018-06-27 Boston Scientific Scimed, Inc. Alternative placement of thermal sensors on bipolar electrode
US9532725B2 (en) 2014-03-07 2017-01-03 Boston Scientific Scimed Inc. Medical devices for mapping cardiac tissue
JP2017509399A (en) 2014-03-11 2017-04-06 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device for mapping heart tissue
US10610292B2 (en) 2014-04-25 2020-04-07 Medtronic Ardian Luxembourg S.A.R.L. Devices, systems, and methods for monitoring and/or controlling deployment of a neuromodulation element within a body lumen and related technology
US20150317899A1 (en) 2014-05-01 2015-11-05 Covidien Lp System and method for using rfid tags to determine sterilization of devices
CA2948855A1 (en) 2014-05-16 2015-11-19 Applied Medical Resources Corporation Electrosurgical system
KR102420273B1 (en) 2014-05-30 2022-07-13 어플라이드 메디컬 리소시스 코포레이션 Electrosurgical instrument for fusing and cutting tissue and an electrosurgical generator
WO2016081606A1 (en) 2014-11-19 2016-05-26 Advanced Cardiac Therapeutics, Inc. Systems and methods for high-resolution mapping of tissue
JP6673598B2 (en) 2014-11-19 2020-03-25 エピックス セラピューティクス,インコーポレイテッド High resolution mapping of tissue with pacing
SG11201703943VA (en) 2014-11-19 2017-06-29 Advanced Cardiac Therapeutics Inc Ablation devices, systems and methods of using a high-resolution electrode assembly
CA2972029C (en) 2014-12-23 2023-07-04 Richard LE Bipolar electrosurgical sealer and divider
USD748259S1 (en) 2014-12-29 2016-01-26 Applied Medical Resources Corporation Electrosurgical instrument
US9636164B2 (en) 2015-03-25 2017-05-02 Advanced Cardiac Therapeutics, Inc. Contact sensing systems and methods
US10575901B2 (en) 2015-12-24 2020-03-03 Biosense Webster (Israel) Ltd. Estimating a temperature during ablation
US10213253B2 (en) 2015-12-24 2019-02-26 Biosense Webster (Israel) Ltd. Estimating a temperature during ablation
JP6923549B2 (en) 2016-03-15 2021-08-18 エピックス セラピューティクス,インコーポレイテッド Improved system for irrigation cauterization
US10653480B2 (en) 2016-04-28 2020-05-19 Biosense Webster (Israel) Ltd. Method for constructing irrigated balloon catheter with flexible circuit electrode assembly
US10638976B2 (en) 2016-04-28 2020-05-05 Biosense Webster (Israel) Ltd Method of constructing irrigated balloon catheter
US20170347896A1 (en) * 2016-06-02 2017-12-07 Biosense Webster (Israel) Ltd. Balloon catheter and related impedance-based methods for detecting occlusion
US11172821B2 (en) 2016-04-28 2021-11-16 Medtronic Navigation, Inc. Navigation and local thermometry
EP3614946A4 (en) 2017-04-27 2021-03-17 EPiX Therapeutics, Inc. Determining nature of contact between catheter tip and tissue
WO2018227268A1 (en) * 2017-06-12 2018-12-20 Kardium Inc. Medical device systems and methods for activating transducers based on delivery shaft member temperature
CN109870342A (en) * 2017-12-04 2019-06-11 蒙大纳仪器公司 Analysis instrument, method and component
EP3846717A1 (en) 2018-09-05 2021-07-14 Applied Medical Resources Corporation Electrosurgical generator control system
US11696796B2 (en) 2018-11-16 2023-07-11 Applied Medical Resources Corporation Electrosurgical system
USD968422S1 (en) 2019-05-31 2022-11-01 Biosense Webster (Israel) Ltd. Display screen with transitional graphical user interface
USD968421S1 (en) 2019-05-31 2022-11-01 Biosense Webster (Israel) Ltd. Display screen with a graphical user interface
USD969138S1 (en) 2019-05-31 2022-11-08 Biosense Webster (Israel) Ltd. Display screen with a graphical user interface
CN112932659A (en) * 2021-01-26 2021-06-11 上海优医基微能医疗科技有限公司 Microwave ablation electrode needle and ablation system thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4860744A (en) * 1987-11-02 1989-08-29 Raj K. Anand Thermoelectrically controlled heat medical catheter
US4907589A (en) * 1988-04-29 1990-03-13 Cosman Eric R Automatic over-temperature control apparatus for a therapeutic heating device
US4998933A (en) * 1988-06-10 1991-03-12 Advanced Angioplasty Products, Inc. Thermal angioplasty catheter and method
US5191883A (en) * 1988-10-28 1993-03-09 Prutech Research And Development Partnership Ii Device for heating tissue in a patient's body
US5057105A (en) * 1989-08-28 1991-10-15 The University Of Kansas Med Center Hot tip catheter assembly
US5122137A (en) * 1990-04-27 1992-06-16 Boston Scientific Corporation Temperature controlled rf coagulation
US5180896A (en) * 1990-10-11 1993-01-19 University Of Florida System and method for in-line heating of medical fluid
US5348554A (en) * 1992-12-01 1994-09-20 Cardiac Pathways Corporation Catheter for RF ablation with cooled electrode

Also Published As

Publication number Publication date
EP0767628B1 (en) 2004-01-14
WO1996000528A1 (en) 1996-01-11
JP3682066B2 (en) 2005-08-10
ES2216016T3 (en) 2004-10-16
EP0767628A4 (en) 1998-05-06
US5755715A (en) 1998-05-26
WO1996000040A1 (en) 1996-01-04
ATE257675T1 (en) 2004-01-15
CA2194071A1 (en) 1996-01-11
DE69532447D1 (en) 2004-02-19
US5702386A (en) 1997-12-30
JPH10506544A (en) 1998-06-30
DE69532447T2 (en) 2004-11-04
EP0767628A1 (en) 1997-04-16

Similar Documents

Publication Publication Date Title
CA2194071C (en) Non-linear control systems and methods for heating and ablating body tissue
US5906614A (en) Tissue heating and ablation systems and methods using predicted temperature for monitoring and control
US6022346A (en) Tissue heating and ablation systems and methods using self-heated electrodes
US6293943B1 (en) Tissue heating and ablation systems and methods which predict maximum tissue temperature
CA2217538C (en) Systems and methods for ablating body tissue using predicted maximum tissue temperature
US5743903A (en) Cardiac ablation systems and methods using tissue temperature monitoring and control
EP1592355B1 (en) Ablation system
EP1401346B1 (en) Ablation system
US5688267A (en) Systems and methods for sensing multiple temperature conditions during tissue ablation
US5800432A (en) Systems and methods for actively cooling ablation electrodes using diodes
US6030379A (en) Systems and methods for seeking sub-surface temperature conditions during tissue ablation
US6056745A (en) Systems and methods for obtaining desired lesion characteristics while ablating body tissue
US6053912A (en) Systems and methods for sensing sub-surface temperatures in body tissue during ablation with actively cooled electrodes
JP2007222687A (en) Living tissue heating and ablation system and method using predicted temperature for monitoring and control
US20110152857A1 (en) Apparatus and Methods For Electrophysiology Procedures
WO1996039967A1 (en) Tissue heating and ablation systems and methods which predict maximum tissue temperature
EP0823842A2 (en) Systems and methods for sensing sub-surface temperatures in body tissue during ablation with actively cooled electrodes
US20210015552A1 (en) Patch electrode including temperature sensing circuit and methods of using same

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed